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CHAPTER I 
INTRODUCTION 
Medical Importance of Venomous Snakes 
Humanity's relationship with serpents throughout recorded history has 
been a tenuous one at best. The snake has long been the subject of fear as well 
and reverence. In more recent decades, as human knowledge and 
understanding of nature have continued to increase, we have learned that which 
makes some snakes fearsome, their venoms, can not only be combated but also 
harnessed as useful tools for the betterment of humanity. Snake venoms merit a 
great deal of attention as in many parts of the world they represent serious 
human health concerns. Approximately 15 % of the 3000 known species of 
snakes are venomous. Venomous snakes are classified into the families 
Viperidae, Elapidae, Hydrophidae and Colubridae (MEHRTENS, 1987). In the 
United States only envenomation by members of the families Elapidae (coral 
snake) and Viperidae (copperheads, rattlesnakes, cottonmouths) produce 
medical problems. Snakebite envenomations can induce a variety of systemic 
pathologies ipduding cardiovascular and respiratory dysfunctions, hypotension, 
neurological disorders, and coagulopathies (GOMEZ and DART, 1995). Lethality 
is usually attributed to respiratory failure and shock (GOMEZ and DART, 1995). 
It has been estimated that approximately 8000 poisonous snake bites occur in 
the U. S. annually (PARRISH, 1966) with less than 0.5 % of these being fatal 
(PARRISH, 1966; RUSSELL, 1983). This is a great improvement over the fatality 
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rate of 5-25 % seen at the beginning of the twentieth century (GOMEZ and DART, 
1995). Polyvalent (Crotalidae) antivenin (Wyeth) is currently used almost 
exclusively in U. S. hospitals for the treatment of snakebite envenomation. The 
low mortality rate of poisonous snake bites may be at least partially attributable 
to the use of this product (RUSSELL, 1983). Snake venoms also elicit serious 
damage to local tissues. These local effects of snake venoms include 
myonecrosis, edema, and hemorrhage (OWNBY, 1982). If unchecked these effects 
may result in permanent tissue loss, severe disfigurement, immobilization, and 
even the necessity of amputation (GOMEZ and DART, 1995). Thus, while the 
threat of death from poisonous snake bites may not be particularly alarming, the 
maiming, scarring, and debilitation due to the effects of snake venom on local 
tissues can be quite serious~ 
Venom-induced hemarrhage 
Upon gross observation snake venom-induced hemorrhage may present 
itself as either diffuse petechiation or ecchymosis surrounding the point of 
envenomation (GOMEZ and DART, 1995). Hemorrhage not only has a direct 
effect on tissues, but also can produce indirect effects due to ischemia by simple 
loss of vascularization to a tissue or shifts in the tissue distribution of circulating 
blood volume to compensate for blood lost in hemorrhage (PRICE et al., 1993). In . 
very severe cases, blood loss due to local and systemic hemorrhage may make a 
significant contribution to the lethality of a venom or may exacerbate 
circumstances in a synergistic fashion with the effects of other venom 
components (KAMIGUTI et al., 1992). 
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Hemorrhagic toxins 
It is now well-established that venom-induced hemorrhage is primarily 
the result of hemorrhagic metalloproteinases (MEIER and STOCKER, 1995). To 
date there have been approximately 80 snake venom hemorrhagic toxins isolated 
and characterized (Table 1). Snake venom hemorrhagic toxins are zinc-
dependent metalloproteinases ranging in size from 15 to 100 kD and having 
activity against a wide variety of substrates (MARSH, 1994; BJARNASON and FOX, 
1994) (Table 1). Studies on the structural and functional similarities of 
hemorrhagic toxins have revealed two structural features which are thought to 
be common to all. Firstly, sequence analysis of several snake venom 
hemorrhagic toxins revealed the presence of an amino acid motif characteristic of 
zinc-dependent metallopeptidases (JONGENEEL et al., 1989; JIANG and BOND, 
1992). This distinguishing signature of snake venom metalloproteinases is 
formed by a conserved amino acid consensus sequence of HEBXHXBXXHX ("B" 
= bulky, apolar residue; "E" = glutamic acid; "H" = histidine; "X" = variable 
residue) containing the active zinc-binding site (KINI and EVANS, 1992; 
BJARNASON and Fox, 1994). Secondly, snake venom metalloproteinases, 
including hemorrhagic toxins, also have a highly conserved methionine-
containing turn (met-turn) in which methionine is contained in the sequence 
CIMXP ("C" = cysteine; "I" = isoleucine; "M" = methionine; "X" = variable 
residue; "P" = praline) (BJARNASON and Fox, 1994). Snake venom hemorrhagic 
toxins have thus been classified as belonging to the reprolysin family of zinc-
metalloproteinases, a family within the metzincin superfamily of enzymes. This 
family also includes certain mammalian reproductive enzymes (HOOPER, 1994) 
such as PH-30a, PH-30b, EAP I, and Cyritestin (WOLFSBERG et al., 1993). 
TABLE 1. CHARACTERISTICS OF KNOWN HEMORRHAGIC TOXINS ISOLATED FROM SNAKE VENOM 
Veno Toxin MW pl Substrates MHD Effect +CHO Inhibitors Ref. 
m (Kd) {µg) onFg 
Agkistrodon acutus 
AC1-protease 24.5 4.7 casein, insulin B, Fg, 0.22 a N.D. EDTA, cys. NIKAI etal., 1977 
azocasein, HP A, 
azoalbumin 
ACz-protease 25 4.9 casein 0.43 EDTA, cys. SUGIHARAet al., 1978 
AC3-protease 57 4.7 . Fg 0.95 a&~ 0.1% EDTA, cys. YAGAHASHI et al., 1986 
AC4-protease 33 4.4 casein 0.31 EDTA, cys. SUGIHARAet al., 1980 
A Cs-protease 24 6.7 casein 0.37 EDTA, cys. MORI et al., 1984 
FP 24 3.8 Fg 3.81 a EDTA, cys. 0UYANG and HUANG, 1976 
Aa-toxin I 22 4.6 casein 0.4- EDTA, cys. Xu et al., 1981 
2.5 
Aa-toxin II 22 5.3 fibrin? 1.5 cys. Xu et al., 1981 
Aa-toxin III 22 >9 10.0 Yes EDTA ·· Xu et al., 1981 
Agkistrodon bilineatus 
Bilitoxin 48 + lMAiet al., 1989 
A. contortrix laticinctus 
ACLHT-1 29 acidic DMC, Fg 8.5 a>~ EDTA JOHNSON and OWNBY, 1993 
A. halys blomhoffii 
HR-I 85 4.7 azocasein, 0.0012 12% EDTA; cys. OSHIMA et al., 1972; NIKAI et 
azoalbumin al., 1986 
HR-II 95 4.2 casein 0.19 7-8% EDT A, thiols OsHIMA et al., 1968; OsHIMA et 
al., 1971 
Atractaspis engaddensis 50 acidic 0.2 Yes EDTA OV ADIA, 1987 
Bitis arietans 
BHRa 68 casein, HP A, gelatin, 0.02 EDTA, cys. 0MORI-SATOH et al., 1995; 
collagen, insulin B YAMAKAWA et al., 1995 
BHRb 75 casein, HP A,gelatin, 0.014 EDTA, cys. 0MORI-SATOH et al., 1995; 
collagen, insulin B YAMAKAWA et al., 1995 
HT-1 N.D. ? casein MEBS and P ANHOLZER, 1982 
~ 
Table 1 cont'd. 
Venom Toxin MW pl Substrates MHD Effect +CHO Inhibitors Ref. 
(Kd) (µg) onFg 
Bitis gabonica 70 BENNET and MARSH, 1993 
B othrops asper 
BHl (BaHl) 64 4.5 0.2 EDTA BORKOW et al., 1995 
BH2 26 5.2 2.0 EDTA BORKOW et al., 1993 
BH3 55 5.0 1.6 EDTA BORKOW et al., 1993 
BaPl 24 casein, HP A, F g 20 a.>~ EDTA GUTIERREZ et al., 1995 
Bothrops jararaca 
HFl + 0.1 AsSAKURAet al., 1986 
HF2 50 casein, insulin B 0.02 AssAKURAet al., 1986; 
MANDELBAUM et al., 1976 
HF3 62 + 0.015 AssAKURAet al., 1986 
Bothropasin 48 N.D. casein, insulinB N.D. N.D. EDTA,EGTA MANDELBAUM et al., 1982 
Jararhagin 52 fibrin PAINE et al., 1992 
Bothrops moojeni 
Protease A 20.4 7.7 casein weak EDTA AssAKURA et al., 1985 
Bothrops neuwiedi 
NHFa 46 4.2 casein EDTA MANDELBAUM et al., 1984 
NHFb 58 4.3 casein EDTA MANDELBAUM et al., 1984 
Calloselasma rhodostoma 
Rhodostoxin 23.4 Yes 15 % CHUNG et al., 1993, 1996 
HP-1 38 BANDO et al., 1991 
Cerastes cerastes 
Cerastase F-4 22.5 200 DAOUD et al, 1986 
Crotalus adamanteus 
Proteinase H 85.7 6.1 casein 0.02 EDTA KURECKI and KRESS, 1985 
Crotalus atrox 
HT a 68 6.1 insulin B 0.04 EDTA BJARNASON and Tu, 1978; 
OWNBY et al., 1978 
HTb 24 basic Fg 3.0 a.>~ EDTA BJARNASON and Tu, 1978; 
OWNBY et al., 1978 
(JJ 
Table 1 cont'd. 
Venom Toxin MW pl Substrates MHD Effect +CHO Inhibitors Ref. 
(Kd) (µg) onFg 
HTc 24 6.0 casein 8.0 EDTA BJARNASON and Tu, 1978; 
BJARNASON and Fox, 1987 
HTd 24 6.1 casein 11.0 EDTA BJARNASON and Tu, 1978; 
BJARNASON and Fox, 1987 
HTe 25.7 5.6 casein 1.0 EDTA BJARNASON and Tu, 1978 
HT/ 64 7.7 insulin B, Fg 0.53 y NIKAI et al., 1984 
HTg 60 6.8 1.4 NIKAI et al., 1985a 
Crotalus basilicus basilicus 
B-1 27 + <10 MOLINA et al., 1990 
B-2 27.5 + <10 MOLINA et al., 1990 
Crotalus horridus horridus 
Protease IV (HP 57 5.1 Fg, azocoll 4.0 a>p EDTA CIVELLO et al., 1983a, b 
IV) 
Crotalus ruber ruber 
HT-1 60 5.8 Fg 0.17 a>P EDTA MORI et al., 1987 
HT-2 24 5.2 Fg 0.27 a EDTA MORI et al., 1987 
HT-3 25 9.6 Fg 1.43 a EDTA MORI et al., 1987 
Crotalus scutulatus scutulatus 
P-13 27 + 1-2 MARTINEZ et al., 1990 
Crotalus viridis viridis 
54 DMC, azocasein, 0.11 a&p N.D. EDTA, DTT, KOMORI et al., 1994 
casein, azoalbumin, phen 
azocoll, HP A 
68 8.5 DMC,Fg N.D. a + EDT A, NaI04, LI et al., 1993 
PNGaseF 
62 4.1 DMC,Fg N.D. a + EDT A, Nal04, LI et al., 1993 
PNGaseF 
Lachesis muta muta 
LFH-1 100 insulin B, F g + SANCHEZ et al., 1987; 
SANCHEZ et al., 1995 
°' 
Table 1 cont'd. 
Veno Toxin MW pl Substrates MHD Effect +CHO Inhibitors Ref. 
m (Kd) (µg) onFg 
LHF-II 22.3 6.6 insulin B, Fg, casein, N.D. a. N.D. EDTA, EGTA, SANCHEZ et al., 1991 
DMC, HPA, fibrin phen; 
Notechis scutatus scutatus 
HTa-HTi 18-21 acidic FRANCIS et al., 1993 
Ophiophagus hannah 
Hannahtoxin 66 + 0.7 TAN and SAIFUDDIN, 1990 
Philodryas olfersii 
I 58-70 casein EDTA, cys. AsSAKURA et al., 1992 
II 47 Fg, casein a.> p EDTA, cys. AssAKURA et al., 1992 
Trimeresurus elegans 
T. elegans 28.5 7.4 Fg, DMC, HPA, 10 p N-BS, BZA NIKAI et al., 1991 
hemorrhgic insulin B 
toxin 
Trimeresurus flavoviridis 
HR la 60 4.4 casein 0.016 17- EDTA, cys. 0MORI-SATOH and SADAHIRO, 
18% 1979 
HR lb 60 4.4 casein 0.01 17- EDTA, cys. 0MORI-SATOH and SADAHIRO, 
18% 1979; TAKEYA et al., 1990 
HR-2a 23 8.6 Fg 0.07 a. EDTA, cys. TAKAHASHI and 0HSAKA, 1970; 
NIKAI et al., 1987 
HR-2b 25.5 9.2 Fg 0.07 a. EDTA, cys. TAKAHASHI and 0HSAKA, 1970; 
NIKAI et al., 1987 
Trimeresurus gramineus 
HRl 23.5 >10 F g, casein, azocoll 2.5- a. 4% EDTA HUANG et al., 1984 
5.0 
HR2 81.5 1.3- a., p 10% EDTA? HUANG et al., 1984 
2.5 
P-fibrinogenase 25 4.5 Fg p >a. 7% PMSF 0UYANG and HUANG, 1979 
'.:J 
Table 1 cont'd. 
Veno Toxin MW pl Substrates MHD Effect +CHO Inhibitors Ref. 
m (Kd) (µg) onFg 
Trimeresurus mucrosquamatus 
Mucrotoxin a 94 4.3 casein 2.31 EDTA,DFP SUGIHARA et al., 1983 
HR-a 15 4.7 Fg, insuhn B 1.7 ~ EDTA, phen. NIKAI et al., 1985b 
HR-b 27 8.9 Fg, insuhn B 2.3 (X, NIKAI et al., 1985b 
Vipera ammodytes ammodytes 
HT-1 60 basic insuhn B BJARNASON and Fox, 1994 
HT-2 60 acidic insuhn B BJARNASON and Fox, 1994 
HT-3 60 acidic insuhn B BJARNASON and Fox, 1994 
Vipera aspis aspis 
67 0.11 KOMORI and SUGIHARA, 1988 
Vipera berus berus 
HMP 56.3 N.D. casein, F g, insuhn B N.D. (X, N.D. EDTA SAMEL and SIIGUR, 1990 
Vipera lebetina 
Lebetase 23.7 + SIIGUR and SIIGUR, 1991 
Vipera palestinae 
HRl 60 basic gelatin, casein 0.2 + OVADIA, 1978 
HR2 60 weak -on casein, gelatin 0.2 OVADIA, 1978 
acidic 
HR3 60 acidic - on casein, gelatin 0.4 OVADIA, 1978 
Abbreviations: MHD: minimum hemorrhagic dose (µg/ g); cys.: cysteine; DMC: N,N-dimethylated casein; Fg: fibrinogen; phen: 1,10-
phenanthrohne; BZA: benzamidine-HCl; N-BS: N-bromosuccinimide; HPA: hide powder azure;-: not detected+: property detected, not 
quantified; N. D.: not determined. 
00 
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Comparative analyses of amino acid sequences of snake venom toxins 
have also revealed similarities in the sequences of hemorrhagic toxins and some 
putative disintegrin precursor molecules {KINI and Ev ANS, 1992). These 
similarities have led to the hypothesis that snake venom metalloproteinases, 
including hemorrhagic toxins, and disintegrins {platelet aggregation inhibitors) 
may be derived by proteolytic processing of common precursor proteins 
comprised of four distinct domains, designated A-D. The metalloproteolytic 
domain is proposed to lie within domain D while domain C is the disintegrin-
like domain. Indeed, some hemorrhagic toxins have been found to contain both 
a metalloproteolytic site and a disintegrin or disintegrin-like domain (T AKEY A et 
al., 1993b; BJARNASON and Fox, 1995 a, b). 
Mechanism of action of snake venom hemorrhagic toxins 
The aforementioned zinc-binding active site and its associated proteolytic 
activity are currently thought to be keys to. the mechanism of biological action of 
snake venom hemorrhagic toxins. As previously mentioned, these toxins cause 
hemorrhage by disrupting the microvasculature of tissues. There are two 
possible mechanisms by which hemorrhage may occur: per rhexis and per 
diapedesis. In hemorrhage per rhexis, the endothelium and often its associated 
basal lamina is disrupted or destroyed while the intracellular junctions remain 
intact. In hemorrhage per diapedesis the intracellular junctions of endothelial cells 
are opened, allowing erythrocytes to escape; Ultrastructural studies have shown 
that in many snake venoms hemorrhagic toxins cause hemorrhage per rhexis 
{OWNBY, 1990). However, some hemorrhagic toxins are thought to cause 
hemorrhage per diapedesis (OHSAKA, 1979; TSUCHIYA et al., 1978). 
Until recently very little work had been done on the direct effects of 
venoms and hemorrhagic toxins on endothelial cells. One recent study 
10 
demonstrated that different hemorrhagic toxins exhibited similar cytotoxic 
effects on endothelial cells in culture as determined by a neutral red dye assay 
(OBRIG et al., 1993). In that study hemorrhagic toxins from C. ruber ruber (HT-1 
and HT-2) and C. atrox (atroxase, HT-a and HT-d) were found to be cytotoxic in 
tissue culture to microvascular endothelial cells. They were not cytolytic. In vivo 
cell lysis seems necessary for hemorrhage to occur. Another study was 
conducted using cultured murine microvascular endothelial cells treated with a 
hemorrhagic metalloproteinase as well as a non-hemorrhagic PLA2-like 
myotoxin (LOMONTE et al., 1994). In that study no cytotoxicity was observed in 
the hemorrhagic toxin-treated cells. These cells, however, were observed to 
detach from their substratum. The myotoxin was shown to be cytotoxic to these 
same cells by causing lysis of their plasma membranes. Thus, the conflicting 
data from these two studies have created some controversy regarding the 
mechanism of action of snake venom hemorrhagic toxins. 
It is likely that there is more than one mechanism of action for the many 
different known hemorrhagic toxins. In general, hemorrhagic toxins are thought 
to digest or disrupt the proteins comprising the endothelial basal lamina, leading 
to subsequent endothelial cell disruption and hemorrhage per rhexis (T AKEY A et 
al., 1993a). The recent studies mentioned above on the effects of hemorrhagic 
toxins on endothelial cells in vitro would seem to support this theory (OBRIG et 
al., 1993; LOMONTE et al., 1994; BORK.OW et al., 1995). Some hemorrhagic toxins 
have also been shown to proteolytically degrade proteins of the capillary basal 
lamina in vitro (BARAMOV A et al., 1989). The in vitro degradation of basal lamina 
proteins, however, occurs over a period of several hours whereas hemorrhage 
induced in vivo by hemorrhagic toxins is known to occur within minutes or even 
seconds (OWNBY, 1990). Electron micrographs of capillaries, in cases of snake 
venom/toxin induced hemorrhage, often possess intact or only partially 
11 
disrupted basal laminae (OWNBY et al., 1978; OWNBY and GEREN, 1987). In vitro 
assays have shown hemorrhagic toxins to be general proteases exhibiting 
substrate specificity on a wide variety of different protein substrates. Many of 
these proteins are unrelated to the basal lamina. The degradation of basal 
lamina proteins in vitro is therefore not conclusively indicative of the mechanism 
of hemorrhagic toxin action. It cannot be ruled out, however, that this action 
may play a significant role in the production of hemorrhage in vivo . It is 
possible that degradation of basal lamina proteins and direct cytotoxicity are 
both involved. At any rate, whether microvascular endothelial cell disruption in 
vivo in hemorrhage per rhexis is a primary or secondary event involving snake 
venom hemorrhagic toxins is unclear. 
Other possible mechanisms of hemorrhage include indirect effects of 
hemorrhagic toxins. The fibrinogenolytic and fibrinolytic effects and 
coagulopathies induced by snake venom hemorrhagic toxins have been 
implicated in the induction and complication of hemorrhage (SUGIKI et al., 1995). 
Many hemorrhagic toxins act on fibrinogen and/ or fibrin in vitro, a finding that 
suggests that these toxins may also have an anticoagulant effect exacerbating 
hemorrhage that may be induced by other mechanisms (TU, 1988; KAMIGUTI et 
al., 1992; DECLERCK et al., 1994). 
As previously mentioned, snake venom hemorrhagic toxins may act upon 
several protein substrates associated with microvascular endothelial cells to elicit 
hemorrhage. The substrates include the aforementioned basal lamina proteins 
and possibly other proteins expressed/ secreted by endothelial cells. Two 
particularly intriguing possibilities are von Willebrand Factor (vWF), also 
known as Factor VIII-related antigen (Factor VIIl:RAg), and a distinctly different 
clotting factor, Factor VIII:C. vWF is necessary for the activation of Factor X 
which is responsible for the conversion of prothrombin to thrombin (KORNALIK, 
12 
1991). A systemic deficiency in Factor VIII:C results in classical type A 
hemophilia (BANERJEE et al., 1992). Deficiencies in vWF and Factor VIII can 
result in severe hemophilia. Generally, severe local hemorrhage is commonly 
associated with hemophilia. It is possible that hemorrhagic toxins could induce 
hemorrhage be creating local and sometimes even systemic deficiencies or 
irregularities in these clotting factors. 
The effects of hemorrhagic toxins on endothelial cells and endothelial cell responses to 
m1ury 
Endothelial cells, particularly those forming capillaries (i. e. 
microvascular endothelial cells), have been shown by light and electron 
microscopy to undergo degeneration and necrosis from in vivo injection of 
various snake venom hemorrhagic toxins (OWNBY et al., 1978; MOREIRA et al., 
1994). Currently the only evidence of direct damage to vascular endothelial cells 
in vitro does not correlate well with the extent and timing of damage seen in vivo. 
In vivo hemorrhage per rhexis occurs very rapidly, in most cases within 5-10 
minutes after injection. Toxic effects of hemorrhagic toxins on cultured 
endothelial cells (OBRIG et al., 1993) and the proteolysis of substrates by 
hemorrhagic toxins in vitro (BARAMOV A et al., 1989) require much longer 
periods of time to occur. The discrepancies between the in vivo and in vitro data 
could be explained by simple difference in the experimental conditions and in 
phenotypic expressions of these cells in the different environments. Injury to 
endothelial cells is characterized by release of specific markers such as vWF, 
thrombomodulin, and angiotensin converting enzyme. Release of cytokines and 
vasoactive substances, changes in adhesion molecule expression, complement 
activation, and morphological changes are also indicative of endothelial cell 
injury (Fig. 1) (GRACE, 1994). These responses lead to a series of events 
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including vasoconstriction, alterations in platelet aggregation, and neutrophil 
(PMN) chemotaxis and PMN adherence which can often exacerbate hemorrhage. 
Initial damage to the endothelium such as is seen with hemorrhagic toxins 
undoubtedly leads to further complications brought on by these responses. 
However, in their examination of thirty-eight clinical cases of envenomation by 
Bothrops jararaca, a notoriously hemorrhagic venom, KAMIGUTI et al. (1992) did 
not detect elevated levels of endothelial cell injury markers (e. g. 
thrombomodulin and von Willebrand factor), indicating that there was no 
evidence of direct damage to endothelial cells in vivo. 
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FIG. 1 RESPONSES OF ENDOTHELIAL CELLS TO INJURY AND THEIR CONSEQUENCES 
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Aims of the study 
In 1799, the Eastern diamondback rattlesnake (Crotalus adamanteus) was 
one of the first venomous snakes described as a North American species 
(COLLINS, 1990). Since that time it has been a snake of considerable medical 
importance as it possesses one of the most hemorrhagic snake venoms found in 
North America (HOMMA and Tu, 1971). Incidentally, this venom is also one of 
the four venoms used in the production of the Wyeth polyvalent (Crotalidae) 
antivenom and as such it seems a suitable subject for a study on the elucidation 
of the effects of a hemorrhagic toxin on endothelial cells. 
A better understanding of the mechanism of hemorrhagic toxins at the 
cellular level is needed if a suitable means of preventing or diminishing the 
effects of hemorrhage is to be found. The work that follows is a study of one 
important snake venom hemorrhagic toxin, proteinase H from Crotalus 
adamanteus venom. Three hypotheses are tested in this dissertation. The first 
hypothesis is that the hemorrhagic and proteolytic activity of proteinase H is 
dependent upon its glycosylation. The second hypothesis is that proteinase H 
induces hemorrhage per rhexis. The third hypothesis is that proteinase H is 
directly cytotoxic to human dermal microvascular endothelial cells in culture. In 
addition to testing these hypotheses, several of the biochemical and physical 
characteristics of proteinase H are reported. The pathogenesis of local and 
systemic hemorrhage induced by proteinase H in mice is described and the 
effects of proteinase H on different types of cultured endothelial cells are 
reported. 
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CHAPTER II 
FIBRINOGEN-CLOTTING ACTIVITY OF PROTEINASE H, THE 
HEMORRHAGIC ZINC-METALLOPROTEINASE FROM 
CROTALUS ADAMANTEUS (EASTERN DIAMONDBACK 
RATTLESNAKE) VENOM 
ABSTRACT 
Proteinase H, the sole hemorrhagic factor in the venom of the 
Eastern diamondback rattlesnake, was first isolated from crude 
venom by KURECKI AND KRESS in 1985. In the current study, 
proteinase H was isolated using a modification of their method. Its 
fibrinogen-clotting activity was quantified as 5.0 NIH Units/mg of 
protein. Proteinase H preferentially releases fibrinopeptide B 
(FPB) and digests the B~ subunit of fibrinogen. The fibrinogen-
clotting activity of proteinase H was not inhibited by treatment 
with phenylmethylsulfonyl fluoride (PMSF), a serine protease 
inhibitor, ethylenediaminetetraacetic acid (EDTA), a divalent metal 
cation chelator, or deglycosylation by treatment with peptide N-
glycosidase from Flavobacterium meningosepticum (PNGaseF). These 
data suggest that the fibrinogen-clotting activity of proteinase H is 
not due to serine protease activity, and the activity is not 
dependent on zinc nor the presence of carbohydrate moieties. To 
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our knowledge this is the first report on the influence of a snake 
venom hemorrhagic metalloproteinase on fibri:hogen-clotting in 
vitro. 
INTRODUCTION 
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Proteinase H was first isolated by KURECKI AND KRESS in 1985 as the sole 
hemorrhagic metalloproteinase in Crotalus adamanteus venom. It is a zinc-
dependent proteolytic glycoprotein with a molecular weight of 85.7 kD and a pl 
of 6.1. EDTA was found to inhibit its proteolytic/hemorrhagic activity while 
PMSF had no such inhibitory effect. We have found that this same toxin also 
possesses a thrombin-like property of causing fibrinogen to clot by the formation 
of a network of fibrin polymers. This was serendipitously discovered during the 
routine assay for fibrinogenolytic activity in which instead of degradation of 
fibrinogen into its respective subunits, as is commonly found with this class of 
proteins, the formation of an opaque, dissoluble clot occurred. The study that 
follows describes the purification procedure used in obtaining proteinase H as 
well as the characterization of its fibrinogen-clotting activity. 
MATERIALS AND METHODS 
Venom and reagents 
Crude C. adamanteus (Eastern diamondback rattlesnake) venom from a 
single pool of snakes from Florida was purchased in lyophilized form from 
Biotoxins, Inc. (St. Cloud, FL, U.S.A.). 3-(N-morpholino)-2-
hydroxypropanesulfonic acid (MOPS) was purchased from Calbiochem (La Jolla, 
CA, U.S.A). N,N-dimethlyated casein, bovine thrombin, bovine fibrinogen, 
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TRIZMA® base (Tris[hydroxymethyl] aminomethane), silver nitrate, sodium 
bicarbonate, 2,4,6-trinitrobenzenesulfonic acid (TNBS), PMSF, Gly-His-Pro-Arg 
(acetate salt), ammonium acetate, and sodium periodate (NaI04) were 
purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Ethylenediamine 
tetraacetic acid, disodium salt (EDTA) was purchased from Fisher Scientific Co. 
(Fair Lawn, NJ, U.S.A.). Sodium dodecyl sulfate (SDS) was purchased from Bio-
Rad Laboratories (Richmond, CA, U.S.A). Peptide N-glycosidase F from Vibrio 
cholerae (PNGaseF) was purchased from Boerhinger Mannheim Corp. 
(Indianapolis, IN, U.S. A.). PhastGel electrophoresis media and PhastGel Blue R 
staining kit for Coomassie blue visualization were purchased from Pharmacia 
(Piscataway, NJ, U. S. A.). Acetonitrile was purchased from Aldrich Chemical 
Co. (Milwaukee, WI, U.S. A.). 
Purification of proteinase H 
Proteinase H was isolated by a modification of the liquid 
chromatographic series reported by KURECKI AND KRESS (1985). The procedure 
was modified by replacing the final, anion exchange open column step with an 
HPLC column for greater resolution. In each step the volumes specified are 
collected in test tubes and assayed for absorbance at 280 nm and caseinolytic 
activity. Tubes were pooled according to caseinolytic activity or, in the absence 
of such activity, to absorbance at 280 nm. These pools are referred to as 
fractions. Fractions containing caseinolytic material were then tested for 
hemorrhagic activity. Hemorrhagic fractions were selected for further 
purification as described. Crude C. adamanteus venom (2.0 g) was dissolved in 
0.02 M sodium borate buffer (pH 8.0) containing 0.1 M NaCl and 10 % ethylene 
glycol and initially fractionated on a CM Bio-Gel A cation exchange column (2.6 
X 27 mm). The column was eluted at a flow rate of 20 ml/hr using a step-wise 
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NaCl concentration gradient beginning with 0.1 M NaCl then increasing the 
concentration to 0.3 M and finally to 1.0 M. Five milliliter volumes were 
collected and assayed for caseinolytic activity. Fraction Al was concentrated 
and dialyzed against 0.05 M Tris-HCl (pH 8.0). After dialysis solid KCl was 
added to a final concentration of 1 M. Fraction Al was then fractionated by 
hydrophobic interaction chromatography on a Phenyl Sepharose column (2.6 X 
25 cm). The column was eluted at a flow rate of 50 ml/hr using a step-wise 
gradient from the starting buffer to 0.05 M Tris-HCl (pH 8.0) and finally to 0.05 
M Tris-HCl (pH 8.0) with 50 % ethylene glycol. Five ml volumes were collected 
and assayed for hemorrhagic and caseinolytic activity. Fraction B3 was 
concentrated and dialyzed against 0.1 M Tris, 0.5 M NaCl (pH 8.6), then 
separated by gel filtration chromatography on a Sephacryl S-200 HR column (2.6 
X 100 cm) eluted with the aforementioned buffer at a flow rate of 20 ml/hr. Five 
ml volumes were collected and assayed for hemorrhagic and caseinolytic 
activity. Fraction Cl was concentrated and dialyzed against 0.05 M Tris (pH 
8.0). This material was then separated by semi-preparative anion exchange 
HPLC on a Waters DEAE-5PW column. The column was eluted at 3 ml/min 
using a linear NaCl concentration gradient. Peaks were detected by absorbance 
at 280 nm and 1 ml volumes were collected and assayed for hemorrhagic 
activity. Fraction D2 was determined to be homogeneous and is hereafter 
referred to as proteinase H. Homogeneity was demonstrated by the formation of 
a single band on an SDS-PAGE gel stained with silver nitrate and by obtaining a 
single peak on analytical C18 reversed-phase HPLC. 
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Determination of hemorrhagic activity 
The hemorrhagic activity of fractions was determined by intradermal 
injection of 100 µl samples into the backs of CD-1 white female mice (Charles 
River). After three hrs the mice were killed and the skin from the backs of the 
treated mice removed. If present, a spot of hemorrhage was quantified by 
measuring the widest diameter of the hemorrhagic spot and the diameter of the 
spot at a right angle to the first measurement (OWNBY et al., 1984). These data 
were expressed as hemorrhagic indices that were calculated by multiplying 
these measurements and were expressed in mm2. 
Deglycosylation of proteinase H with PNGaseF 
Proteinase H was deglycosylated as described in LI et al. (1993). Briefly, 
0.4 U of PNGaseF in 2 µl was mixed with 10 µl of a 1 mg/ ml solution of 
proteinase H and the volume made up to 50 µl with 25 mM Tris buffer (pH 7.3). 
This mixture was incubated overnight at 37°C. Deglycosylation was confirmed 
by a negative reaction with PAS stain on an SDS-PAGE gel. 
Test-tube clotting assay 
To quantify the fibrinogen-clotting activity of the toxin the test-tube 
clotting assay described by DOWD et al. (1995) was used. Fifty microliters of a 
solution containing the proteinase H sample to be tested was added to 100 µl of 
30 mg/ ml bovine fibrinogen in phosphate buffered saline (pH 7.4) in 
microcentrifuge tubes. The final concentration of fibrinogen was 20 mg/ ml. The 
tubes were incubated at 37°C and the time taken for fibrin clots to form was 
recorded. If clots did not form within 12 hrs. the sample was considered 
inactive. 
36 
A thrombin standard curve was generated using the same method to 
estimate the clotting activity of proteinase H on fibrinogen. Thrombin was 
added to the fibrinogen solution as described above in the following amounts: 5, 
3, 1, 0.5, 0.3, 0.1, 0.05 and 0.03 NIH Units. The specific fibrinogen-clotting 
activity of the proteinase H treatments described above were estimated by 
comparison to this thrombin standard curve and expressed in NIH Units/mg. 
Fibrinogen-agarose plate assay 
The fibrinogen-agarose plate assay of DOWD et al. (1995) was used. 
Fibrinogen-agarose plates were made by mixing 10 ml of 1 % agarose warmed to 
50°C with 9.5 ml of 0.4 % (w /v) fibrinogen in PBS. This mixture was poured into 
a petri dish (10 cm diam.) and allowed to cool to room temperature to solidify. 
Wells (4 mm diameter) were cut in the agarose and 5 µl aliquots of thrombin or 
proteinase H added to the wells. The plates were covered and then incubated 
for 5 hours at 37°C in a humidified chamber. Following incubation the 
diameters of rings formed around the wells due to fibrin polymerization were 
measured. 
Electrophoretic analysis of fibrin clots 
Fibrin clots produced in 1 ml microfuge tubes during the test-tube clotting 
assay were subjected to reducing SDS-PAGE analysis as described by DOWD et 
al. (1995). Fibrin clots were formed in microfuge tubes and then centrifuged at 
15,000 X g for 15 minutes. The supernatant was removed and the pelleted clot 
washed five times by the addition of 1 ml of PBS, followed by centrifugation at 
15,000 X g for 15 minutes. After the final wash the pellet was resuspended in 100 
µl of SDS-PAGE sample buffer and heated to 100°C for 5 minutes. Reducing 
SDS-PAGE was performed on 12.5 % homogeneous gels using the Pharmacia 
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PhastSystem electrophoresis unit. Gels were visualized by staining with 
Coomassie blue. 
Effect of inhibitors on clotting activity of proteinase H 
The effect of various potential inhibitors on the fibrinogen-clotting activity 
of proteinase H was determined by the test tube clotting assay described above 
following treatment of the toxin with each inhibitor. To determine the effect of 
inhibitors on the fibrinogen-clotting time of proteinase H a 1 mg/ ml aqueous 
solution of proteinase H was mixed with an equal volume of either 50 mM 
EDTA (pH 7.2), 8 mM of PMSF in DMSO, or 150 µM Gly-His-Pro-Arg (a fibrin 
anti-polymerant) prior to the experiment. Following incubation PMSF was 
removed by dialysis. Proteinase H was deglycosylated using the N-glycosidase 
PNGaseF by incubating a solution of 50 µg of proteinase H with 0.4 U of 
PNGaseF overnight at 37°C. The thrombin-clotting time of each preparation and 
electrophoretic analysis of the resultant clots were conducted as described 
above. Electrophoretic analysis was not conducted on clots formed by anti-
polymerant-treated proteinase H. 
De.fibrinating activity 
Proteinase Hin 10 mM Tris-buffered saline (pH 7.5) was injected at doses 
of 0.5 µg/ g and 1.0 µg/ g intravenously via the ventral median tail vein into 
female white mice (CD-1, Charles River) weighing 22-24 grams. After one hour 
the mice were bled from the infraorbital sinus, using 20 µl non-heparinized glass 
microcapillary tubes. The tubes were allowed to sit at room temperature and 
checked for clotting every ten minutes for 1 hr by sequentially breaking the tube 
from the top down. Lack of clotted blood in tubes was considered positive for 
defibrinating activity. 
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Fibrinolytic activity 
To assay for fibrinolytic activity the fibrin plate assay described by CHEN 
et al. (1991) was used. Proteinase H was applied to fibrin gel plates and 
incubated for 4 hours at 37°C in a humidified chamber. Fibrinolytic activity was 
indicated by the appearance of a zone of clearing in the plate surrounding the 
spot of sample application. 
Reversed-phase HPLC analysis of fibrinopeptides 
Release of fibrinopeptides A (FP A) and B (FPB) were analyzed as 
described by MOSESSON et al. (1987). Bovine fibrinogen was brought to a 
concentration of 5 mg/ml in 150 mM NaCl, 50 mM Tris (pH 7.2), and incubated 
in microfuge tubes after the addition of either 0.01 U thrombin or 10 µg of 
proteinase H. Release of FP A and/ or FPB in 100-300 µl of supernatant solution 
from each tube was analyzed by RP-HPLC on a µBondapak C18 column (3.9 X 
300 mm) eluted with a linear gradient of acetonitrile (12% to 28%) buffered with 
25 mM ammonium acetate (pH 6.0). The acetonitrile gradient was performed 
over 45 minutes with a flow rate of 1 ml/ min. Peptides were detected by 
absorbance at 210 nm. 
Transmission electron microscopic analysis of fibrin clots 
Fibrin clots were formed on 200 mesh carbon-coated, Formvar copper 
grids as described in WEISEL (1986). The grids were first dipped in a solution 
containing 10 NIH U /ml of either thrombin or proteinase H. After coating with 
these clotting agents, 25 µl drops of fibrinogen (2 mg/ml in 150 mM NaCl, 50 
mM Tris, pH 7.2) were applied to each grid. These grids were then incubated 
overnight at room temperature (approximately 20°C) in a humidified container. 
Following incubation the grids were removed from the now clotted fibrinogen 
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droplets and negatively contrasted with 2% uranyl acetate in 10% acetone for 30 
seconds. The fibers thus prepared were then examined by TEM at 80 kV at 
4,800, 10,000, and 100,000 ti.mes magnification. 
RESULTS 
Purification of proteinase H 
Cati.on exchange chromatography of crude venom on CM Bio-Gel A 
yielded a hemorrhagic fraction containing 812.6 mg of material (Fig lA). Tubes 
20-42 containing hemorrhagic material were pooled as fraction Al. Further 
purification of this hemorrhagic fraction was carried out by hydrophobic 
interaction chromatography (HIC) on Phenyl-Sepharose column. Tubes 170-177 
contained all detectable hemorrhagic activity and were pooled as fraction B3. 
Fraction B3 (approximately 35 mg) was the only hemorrhagic fraction to elute 
from the column. It was eluted by 0.05 M Tris-HCl, pH 8.0 (Fig. lB). This 
material was concentrated, dialyzed against 0.1 M Tris (pH 8.6) containing 0.5 M 
NaCl, and subjected to gel filtration chromatography on a Sephacryl S'-200 HR 
column (Fig. lC). Tubes 40-65 contained all detectable hemorrhagic activity and 
were pooled as fraction Cl. The high molecular weight fraction (Cl) was the 
only hemorrhagic fraction eluting from the column. A total of 20.1 mg of 
material was collected in this fraction and purified further by DEAE anion 
exchange HPLC (Fig. lD). Tubes 50-56 contained all detectable hemorrhagic 
activity and were pooled as fraction D2. Fraction D2 began eluting from the 
DEAE column at a NaCl concentration of approximately 0.23 M. A total of 13.1 
mg of protein was obtained (Table 1). This material was judged to be 
homogeneous by virtue of the formation of a single band on SDS-PAGE stained 
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with silver nitrate (Fig. 2) and by analytical C18 RP-HPLC (Fig. 3) and was used 
for these studies. 
Fibrin clot formation by proteinase H 
When 10 µg of proteinase H was added to a solution of bovine fibrinogen 
a stable, gel-like clot formed within 152 ± 22 minutes (n=3). The clot thus 
formed was distinguishable from that formed by thrombin in that the proteinase 
H-generated clot was more opaque. This increased opacity was evident in the 
fibrinogen-agarose plate assay as a distinct, opaque ring (Fig. 4). Pre-treatment 
of the enzyme with EDTA, PMSF, or PNGaseF did not inhibit this activity (Table 
2). Thus, proteinase H had a clotting activity equal to 5.0 X l0-3 NIH Units of 
thrombin, giving proteinase Han estimated specific clotting activity of 5.0 NIH 
Units/mg protein. The thrombin standard to which proteinase H was compared 
had a specific activity of 105 NIH U / mg. 
De.fibrinating and .fibrinolytic activity 
Proteinase H exhibited no defibrinating action when injected 
intravenously into mice. Clot formation was observed in as little as ten minutes. 
Proteinase H did not create a zone of clearing in a fibrin gel plate, indicating the 
absence of any fibrinolytic activity. 
Effect of inhibitors and deglycosylation on .fibrinogen-clotting activity 
Treatment of proteinase H with 4 mM PMSF or with 25 mM EDTA had no 
statistically significant effect (p<0.05) on its mean thrombin-clotting time (Table 
2). This is an interesting note because in other studies by our lab it was found 
that treatment of proteinase H with either EDTA or PNGaseF abolished its 
hemorrhagic activity and proteolytic action on Azocoll™, a modified form of 
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collagen, and N,N-dimethlyated casein (Chapter III). However, while EDTA-
treatment and deglycosylation did not inhibit clot formation, both inhibited the 
digestion of the B~ subunit of fibrinogen (Fig. 5). EDTA-treatment and 
deglycosylation resulted in the formation of a clot which was physically 
indistinguishable from that formed by thrombin. Neither EDTA-treatment nor 
deglycosylation had any effect on the diameter of the precipitin ring formed in 
the fibrinogen-agarose plate assay (Table 3). 
Fibrinopeptide release 
Fibrinopeptide release during treatment with proteinase H was compared 
to that due to treatment with thrombin. The mean peak areas of FP A and FPB 
released from fibrinogen treated with thrombin were 4.72 x 10s ± 3.15 x 105 
µV•sec and 1.34 x 106 ± 1.84 x 10s µV•sec respectively. In comparison, the mean 
peak areas of FP A and FPB released from proteinase H-treated fibrinogen were 
5.46 x 104 ± 1.05 x 104 µV•sec and 1.10 x 106 ± 1.45 x 10s µV•sec respectively. 
Treatment of bovine fibrinogen with proteinase H therefore resulted in the 
preferential release of FPB. Approximately 82 ± 11 % of the FPB released by 
treatment with thrombin was released by proteinase H treatment. Conversely, 
only 12 ± 2 % of the FPA released by thrombin was released by proteinase H. 
Electron microscopic analysis of fibrin clot 
The fibrin network formed by treatment of fibrinogen with proteinase H 
was qualitatively similar in appearance to that formed by treatment with 
thrombin at all the magnifications viewed. This procedure was carried out to 
confirm that the phenomenon being observed following treatment was due 
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FIG. 1 (cont'd). lsOLATION OF PROTEINASE H. (C) Fraction B3 was separated on 
a Sephacryl S-200 HR column. The column was eluted with 0.1 M Tris, 0.5 M 
NaCl, pH 8.6 using a flow rate of 20 ml/hr and fractions were collected in 5 ml 
volumes. (D) Fraction Cl was separated on a Waters DEAE-SPW semi-
preparative HPLC column. The column was eluted using a linear NaCl 
concentration gradient at a flow rate of 3 ml/ min. Fractions were collected in 1 
ml volumes Fraction D2 was determined to be homogeneous by SDS-PAGE and 
analytical C18 RP-HPLC. 
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FIG. 2 SDS-PAGE OF PROTEINASE H. Native and deglycosylated proteinase H 
were separated on a 20% T denaturing SDS-PAGE gel and visualized with silver 
nitrate to demonstrate homogeneity. MW - molecular weight markers; Lane 1 -
proteinase H; Lane 2- deglycosylated proteinase H. Homogeneity is indicated 
by the formation of a single band. 
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FIG. 3 ANALYTICAL C18 RP-HPLC OF PROTEINASE H. Samples of proteinase H 
was subjected to analytical reversed-phase HPLC on a C18 column eluted with a 
linear acetonitrile gradient to further verify the homogeneity of the material 
used in this study. Homogeneity is indicated by the elution of a single peak. 
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TABLE 1. SUMMARY OF PURIFICATION OF PROTEIN ASE H 
Step Yield Total Activity Specific · MHD % Yield! Purification 
(mg) (:emoles / min) Activity+ (µg/g) 
Crude Venom 2000 176.0 58.5 1.0 100 0 
CM Bio-Gel A, 812.6 .73.7 90.7 N.D. 63 1.5 
Fraction Al 
Phenyl- 35.0 9.9 282.9 N.D. 8.5 4.8 
Sepharose, 
Fraction B3 
Sephacryl S-200 20.1 6.6 328.4 N.D. 5.6 5.6 
HR, Fraction Cl 
DEAE-5PW, 13.1 5.6 427.5 0.02 4.8 7.3 
Fraction D2 
lpmoles/min/mg 
*% of total protein yield = mg of fraction/ 2000 mg 
t% of total proteolytic activity= total activity /176 pmoles/min 
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FIG. 4. SDS-PAGE OF FIBRIN CLOTS. Fibrin clots were formed by treatment 
with thrombin or with one of the following proteinase H preparations: native 
proteinase H, PMSF-treated proteinase H, EDTA-treated proteinase H, 
deglycosylated proteinase H. The clots were solubilized in SDS-PAGE buffer as 
described in methods and separated on a 12.5 % T acrylamide gel. Lane 1, 
fibrinogen control; Lane 2, thrombin-generated clot; Lane 3, proteinase H-
generated clot; Lane 4, PMSF-treated proteinase H-generated clot; Lane 5, 
EDTA-treated proteinase H-generated clot; Lane 6 deglycosylated proteinase H-
generated clot. The gel was visualized with Coomassie blue. 
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TABLE 2. EFFECT OF VARIOUS REAGENTS ON THE FIBRINOGEN-CLOTTING ACTIVITY 
OF PROTEIN ASE H 
Treatment Mean Clotting Time Specific Activity 
(minutes) (NIHU/mg) 
aThrombin (0.05 NIH U) 120 ± 36 110 
Proteinase H (50 µg) 56 ±4 2.0 
hProteinase H (10 µg) 148 ± 22 5.0 
Proteinase H + PMSF 148±4 5.0 
Proteinase H + EDTA 152 ± 35 4.2 
Deglycosylated proteinase H 133 ± 11 4.5 
Proteinase H + GP AP 148 ±4 3.5 
a-Thrombin as clotting control. 
b_ Proteinase H control for comparison with inhibitors. 
Proteinase H (10 µg) was treated with the reagents listed in the table and the 
effect on the mean clotting time of proteinase H determined by the test-tube 
clotting assay as described in the methods section. Specific activity of proteinase 
H expressed as NIH Units/mg of protein± 1 SD was determined by comparison 
of clotting time with those of a thrombin standard curve. 
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FIG. 5. FIBRINOGEN-AGAROSE PLATE ASSAY. The zone of clotting induced by (A) 
thrombin or (B) proteinase Hin a fibrinogen-agarose plate is shown. The 
distinct opaque ring (arrowhead) formed by treatment with proteinase His 
shown as an example of the physical difference between clots formed by 
proteinase H and those formed by thrombin. 
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TABLE 3. DIAMETERS OF PRECIPITIN RINGS FORMED IN FIBRINOGEN-AGAROSE 
PLATE ASSAY 
Treatment 
Thrombin ( 0.5 U) 
ProH (10 µg) 
ProH + 25 mM EDTA 
ProH + 4 mM PMSF 
Mean ring diameter 
(mm) 
18.3 ± 0.6 
13.3 ± 0.6 
11 ± 1.0 
12 ± 1.0 
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Proteinase H was determined to have a fibrinogen-clotting activity of approx. 5 
NIH U/mg in an earlier assay. In this fibrinogen-agarose plate assay 0.5 U of 
proteinase H (10 µg) was used to determine the effects of inhibitors on the 
fibrinogen-clotting activity of proteinase H. Thrombin (0.5 U) was used as a 
comparative control. 
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to the formation of a fibrin network as opposed to simple fibrinogen aggregation 
or the formation of fibrinogenin as is induced by treatment of fibrinogen with 
factor XIII alone (BLOMBACK, et al., 1990). 
DISCUSSION 
To date at least sixteen fibrinogen-clotting enzymes have been isolated 
and characterized from snake venoms (PIRKLE AND THEODOR, 1988, 1990; 
STOCKER AND MEIER, 1988). The primary activity of these enzymes is the 
clotting of fibrinogen by the formation of a fibrin network. However, some of 
these enzymes induce platelet aggregation (NISHIDA et al., 1994), factor Xill 
activation, cleavage of synthetic esters, activation of prothrombin, protein C 
(STOCKER AND MEIER, 1988). None of the snake venom fibrinogen-clotting 
enzymes known has all of these activities. We have shown that proteinase H 
from C. adamanteus venom is a fibrinogen-clotting enzyme. The most interesting 
aspect of this activity in proteinase H is that it seems contrary to the apparent 
dominant activity of the toxin, which is to induce hemorrhage. The formation of 
a fibrin clot in or around an area of hemorrhage would seem at first to oppose 
the hemorrhagic effect of the toxin. However, the in vitro fibrinogen-clotting 
activity of proteinase H is relatively weak and its hemorrhagic action is potent. 
The toxin has a MHD of 0.02 µg/ g in mice. There is no evidence that proteinase 
H causes fibrinogen-clotting in vivo. Thus it seems unlikely that the fibrinogen-
clotting activity of proteinase H plays a role in the pathogenesis of hemorrhage 
induced by the toxin in vivo. What is more likely is that this activity of 
proteinase H may have a deleterious effect on hemostatic mechanisms in vivo at 
later time periods, perhaps several hours after the initial introduction of the 
toxin into the body. Continual unregulated activity of such an exogenous 
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fibrinogen-clotting enzyme could conceivably deplete plasma fibrinogen levels, 
predisposing the subject to disseminated intravascular coagulation (MCKAY et 
al., 1970; MAGALHES et al., 1981; KORNALIK, 1991). Intravenous injection of one 
fibrinogen-clotting enzyme from the venom of the bushmaster (Lachesis muta) 
resulted in a 15 % reduction of the total plasma fibrinogen concentration in as 
little as 30 minutes in dogs (MAGALHES et al., 1981). Additionally, the generation 
of fibrinopeptides may stimulate plasmin activity, exacerbating the problem 
(KORNALIK, 1991). 
In the present study proteinase H was treated with several different 
agents that were seen as potential inhibitors of its fibrinogen-clotting activity. 
Specifically, PNGaseF, EDTA and PMSF were tested for any inhibitory effect on 
the fibrinogen-clotting activity of proteinase H. PNGaseF and EDTA were 
selected because they have both been shown to have inhibitory effects on the 
proteolytic and hemorrhagic activities of proteinase H (Chapter III). PMSF was 
selected as it is a serine protease inhibitor, and the activity of other fibrinogen-
clotting or thrombin-like enzymes has been shown to be due to the serine 
protease activity of those enzymes. As expected, PMSF did not inhibit the 
fibrinogen-clotting activity of proteinase H nor the digestion of the Bf3 subunit of 
fibrinogen. Treatment of proteinase H with EDTA or PNGaseF, however, also 
failed to inhibit its fibrinogen-clotting activity. Treatment with EDTA and 
PNGaseF did inhibit the digestion of the Bf3 subunit of fibrinogen, indicating 
that the major proteolytic activity of proteinase H was inhibited by these two 
agents. Thus, inhibition of the proteolytic activity of proteinase H by EDTA and 
deglycosylation prevented the digestion of Bf3 fibrinogen but did not prevent the 
clotting of fibrinogen. 
As to its fibrinogen-clotting activity, proteinase H behaves in a manner 
similar to Venzyme and the fibrinogen-clotting enzyme found in A. halys venom 
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by preferentially releasing FPB, with the weak release of FP A (STOCKER AND 
MEIER, 1988; DYR et al., 1989). Proteinase H also has several features in common 
with cathepsin-L2 from Fasciola hepatica, the only other non-serine proteinase 
reported to cause fibrinogen-clotting (DOWD et al., 1995). Neither proteinase H 
nor cathepsin-L2 are serine-proteases, fibrin anti-polymerants do not inhibit the 
clot-formation catalyzed by either of these agents, and both digest at least one of 
the three fibrinogen subunits. Also, the physical characteristics of the fibrin clot 
formed by both of these proteases is similar. In both cases the clot is less stable 
than that formed by thrombin, collapsing to form a white precipitate upon 
vigorous vortexing. Also, the ring formed by both of these agents in a 
fibrinogen-agarose plate assay is opaque and dense as opposed to the hazy ring 
formed by thrombin. The clots formed by EDTA-treated or deglycosylated 
proteinase H are physically indistinguishable from the thrombin-formed clots 
and electrophoretic analysis of these clots reveals that the a subunit is not 
digested. These findings suggest that the physical difference between the 
thrombin-formed and proteinase H-formed clots are due to this digestion of the 
BJ3 fibrinogen subunit. 
Proteinase H is devoid of esterase activity on the substrates BAEE and 
TAME (KUREC:KI AND KRESS, 1985). A fibrinogen-clotting enzyme from 
Dispholidus typus (boomslang) venom also failed to cleave BAEE when tested 
(HIESTAND AND HIESTAND, 1979). Since esterase activity is not a prerequisite for 
fibrin clot formation, the fibrinogen-clotting activity of proteinase H is probably 
not due to any hidden or residual esterase activity. 
As mentioned a hove, proteinase H is the first snake venom toxin reported 
to possess both a metalloproteinase-dependent hemorrhagic activity as well as 
fibrinogen-clotting activity. This does not exclude other fibrinogen-clotting and 
fibrino(geno )lytic enzymes as hemorrhagic toxins. Of the numerous snake 
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venom fibrinogen-clotting enzymes isolated to date none have been found to be 
hemorrhagic. However, only one such enzyme, ancrod, has been tested for 
hemorrhagic activity in vivo (HATTON, 1973). Conversely, of the many non-
fibrinogen-clotting fibrinogenolytic snake venom enzymes that have been 
isolated several have also been found to be hemorrhagic (CIVELLO et al., 1983; 
NIKAI et al., 1985; KOMORI et al., 1985; NIKAI et al., 1986; TU, 1988). Each of these 
enzymes was isolated primarily as a hemorrhagic toxin and was later 
characterized as being fibrinogenolytic in vitro. It is surprising that of the many 
snake venom enzymes that affect hemostatic components of the blood, so few 
have been tested for both fibrinogen-clotting activity and hemorrhagic activity. 
As such, it seems premature to conclude that fibrinogen-clotting enzymes can 
not also be hemorrhagic. 
In conclusion, our findings indicated that proteinase H is a potent 
hemorrhagic toxin that also possesses fibrinogen-clotting activity. Proteinase H 
releases fibrinopeptide B to induce fibrinogen-clotting and also digests the B~ 
subunit of fibrinogen. 
Acknowledgments: The authors thank Drs. Paulo Melo and Heloisa S. S. Araujo for their help in 
the preparation of this manuscript and Dr. Thomas J. Mohn, Dr. Robert Paul Schwab and Mr. 
Kevin Stepaniuk for critically reading it. 
This study was conducted in partial fulfillment of the requirements for the Ph. D. degree at 
Oklahoma State University for S. G. Anderson and was supported by a Ford Foundation 
Predoctoral Research Fellowship (S. G. A.) and a Public Health Service Grant 5 R01 AI26923-07 
&om the National Institute of Allergy and Infectious Diseases (C. L. 0.). 
61 
REFERENCES 
ALEXANDER, G., GROTHUSEN, J., ZEPEDA, H. and SCHWARTZMAN, R. J. (1988) 
Gyroxin, a toxin from the venom of Crotalus durissus terrificus, is a 
thrombin-like enzyme. Toxicon 26, 953-960. 
BLOMBACK, B., BANERJEE, D., CARLSSON, K., HAMSTEN, A., HESSEL, B., PROCYK, 
R., SILVEIRA, A. and ZACHARSKI, L. (1990) Native fibrin gel networks and 
factors influencing their formation in health and disease, In: Advances in 
experimental medicine and biology, Volume 281: Fibrinogen, thrombosis, 
coagulation, and fibrinolysis (LIU, C. Y. and CHIEN, S., Eds.) New York: 
Plenum Press. 
CHEN, H. M., GUAN, A. L. and MARKLAND, F. S., JR. (1991) Immunological 
properties of the fibrinolytic enzyme · (fibrolase) from southern 
copperhead (Agkistrodon contortrix contortrix) venom and its purification 
by immunoaffinity chromatography. Toxicon 29, 683-694 . 
. CIVELLO, D. J., MORAN, J. B. and GEREN, C. R. (1983) Substrate specificity of a 
hemorrhagic proteinase from timber rattlesnake venom. Biochemistry 22, 
755-762. 
CROWLEY, J. F., GOLDSTEIN, I. J., ARNARP, J. and LONNGREN, J. (1984) 
Carbohydrate binding studies on the lectin from Datura stramonium seeds. 
Arch. Biochem. Biophys. 231, 524-533. 
62 
DOWD, A. J., MCGONIGLE, S. and DALTON, J. P. (1995) Fasciola hepatica cathepsin 
L proteinase cleaves fibrinogen and produces a novel type of fibrin clot. 
Eur. J. Biochem. 232, 241-246. 
DYR, J. E., BLOMBACK, B., HESSEL, B. and KORNALIK, F. (1989) Conversion of 
fibrinogen to fibrin by preferential release of fibrinopeptide B. Biochim. 
Biophys. Acta. 990, 18-24. 
HATTON, M. W. C. (1973) Studies on the coagulant enzyme from Agkistrodon 
rhodostoma venom: isolation and some properties of the enzyme. Biochem. 
J. 131, 799-807. 
HIESTAND, P. C. and HIESTAND, R.R. (1979) Dispholidus typus (boomslang) snake 
venom: purification and properties of the coagulant principle. Toxicon 17, 
489-498. 
KOMORI, Y., HAGIHARA, S., TU, A. T. (1985) Specificity of a hemorrhagic 
proteinase from Crotalus atrox (Western diamondback rattlesnake) venom. 
Biochim. Biophys. Acta 829, 127-130. 
KORNALIK, F. (1991) Influence of snake venom proteins on blood coagulation, 
In: Snake Toxins (Harvey, A. L., Ed.), pp. 323-383. New York: Pergamon 
Press. 
KURECKI, T and KRESS, L. F. (1985) Purification and partial characterization of 
the hemorrhagic factor from the venom of Crotalus adamanteus (Eastern 
diamondback rattlesnake). Toxicon 23, 657-668. 
63 
LI, Q., COLBERG, T. R. and OWNBY, C. L. (1993) Purification and characterization 
of two high molecular weight hemorrhagic toxins from Crotalus viridis 
viridis venom using monoclonal antibodies. Toxicon 31, 711-722. 
MCKAY, D.G., MOROZ, C., DEVRIES, A., CSAVOSSY, I. and CRUES V. (1970) The 
action of hemorrhagin and phospholipase derived from Vipera palestinae 
venom on the microcirculation. Lab. Invest. 22, 387-399. 
MAGALHAES, A., DE OLIVEIRA, G. J. and DINIZ, C. R. (1981) Purification and 
partial characterization of a thrombin-like enzyme from the venom of the 
bushmaster snake, Lachesis muta noctivaga. Toxicon 19, 279-294. 
MOSESSON, M. W., DIORIO, J.P., MULLER, M. F., SHAINOFF, J. R., SIEBENLIST, K. 
R., AMRANI, D. L., HOMANDBERG, G. A., SORIA, J., SORIA, C. and 
SAMAMA, M. (1987) Studies on the ultrastrucure of fibrin lacking 
fibrinopeptide B W-fibrin). Blood 69, 1073-1081. 
NIKAI, T., MORI, N., KISHIDA, M., KATO, Y., TAKENAKA, C., MURAKAMI, Y., 
SHIGEZANE, S. and SUGIHARA, H. (1985) Isolation and characterization of 
hemorrhagic factors a and b from the venom of the Chinese habu snake 
(Trimeresurus mucrosquamatus). Biochim. Biophys. Acta 838, 122-131. 
NIKAI, T., OGURI, E., KISHIDA, M., SUGIHARA, H., MORI, N., TU, A. T. (1986) 
Reevaluation of hemorrhagic toxin, HR-1, from Agkistrodon halys blomhoffii 
venom: proof of proteolytic enzyme. Int. J. Biochem. 18, 103-108. 
64 
NISHIDA, S., FUJIMURA, Y., MIURA, S., OZAKI, Y., USAMI, Y., SUZUKI, M., TIT ANI, 
K., YOSHIDA, E., SUGIMOTO, M., YOSHIKO, A. and FUKUI, H. (1994) 
Purification and characterization of bothrombin, a fibrinogen-clotting 
serine protease from the venom of Bothrops jararaca. Biochemistry 33, 1843-
1849. 
OWNBY, C. L., COLBERG, T. R. and LI, Q. (1994) Presence of heat-stable 
hemorrhagic toxins in snake venoms. Toxicon 32, 945-954. 
OWNBY, C. L., COLBERG, T. R. and ODELL, G. V. (1984) A new method for 
quantitating hemorrhage induced by rattlesnake venoms: ability of 
polyvalent anti.venom to neutralize hemorrhagic activity. Toxicon 22, 227-
233. 
PIRKLE, H. and THEODOR, I. (1988) Thrombin-like enzymes in the study of fibrin 
formation. In: Hemostasis and. Animal Venoms (PIRKLE, H. and 
MARKLAND, F. S., JR., Eds.), pp. 121-141. New York: Marcel Dekker, Inc. 
PIRKLE, H. and THEODOR, I. (1990) Thrombin-like venom enzymes: structure 
and function. In: Fibrinogen, Thrombosis, Coagulation and Fibrinolysis (LIU, 
C. and CHIEN, S., Eds'.), pp. 165-176. New York: Plenum Press. 
65 
STOCKER, K. F. and MEIER, J. (1988) Thrombin-like snake venom enzymes, In: 
Hemostasis and Animal Venoms (PIRKLE, H. and MARKLAND, F. S., JR., 
Eds.), pp. 67-84. New York: Marcel Dekker, Inc. 
TU, A. T. (1988) Hemorrhagic proteases from snake venoms, In: Hemostasis and 
Animal Venoms, (PIRKLE, H. and MARKLAND, F. S., Jr., Eds.), pp. 425-443. 
New York: Marcel Dekker, Inc. 
WEISEL, J. W. (1986) Fibrin assembly: lateral aggregation and the role of the two 
pairs of fibrinopeptides. Biophys. J. 50, 1079-1093. 
CHAPTER III 
PARTIAL CHARACTERIZATION AND THE ROLE OF GLYCOSYL 
MOIETIES OF THE HEMORRHAGIC TOXIN, PROTEINASE H, 
FROM CROTALUS ADAMANTEUS VENOM 
ABSTRACT 
Proteinase H was purified using open column and HPLC liquid 
chromatographic procedures modified from the method first 
reported by KURECKI and KRESS in 1985. The protein gave a 
positive reaction for carbohydrate when stained with periodic acid-
Schiff's reagent. A decrease in the molecular weight of proteinase 
H as estimated by reducing SOS-PAGE was observed following 
removal of sugar moieties with the peptide N-glycosidase from 
Flavobacterium meningosepticum (PNGaseF). The nature of the 
glycosylation was determined by lectin affinity blotting against the 
toxin with Datura stramonium agglutinin (DSA) which is specific 
for glycosyl residues containing the disaccharide galactose-f3(1-4)-
N-acetylglucosamine in complex and hybrid N-glycans (CROWLEY 
et al., 1984). The role of sugar moieties in the proteolytic and 
hemorrhagic activities of proteinase H were studied. Removal of 
sugar moieties by PNGaseF or their oxidation by 0.5 M sodium 
periodate totally abolished the hemorrhagic and proteolytic 
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activity of the toxin. Removal of sialic acid residues by 
neuraminidase from Vivrio cholerae had no effect on hemorrhagic 
activity but resulted in about a 90% decrease in proteolytic activity 
on Azocoll™. These data indicate that the glycosyl moieties of 
proteinase H, in their intact ring formations, are essential to the 
enzymatic and hemorrhagic activity of the toxin. 
INTRODUCTION 
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Approximately 80 hemorrhagic toxins have been isolated from venoms of 
the various poisonous snakes around the world (MARSH, 1994; BJARNASON and 
Fox, 1994). Hemorrhagic toxins are responsible for a large portion of the local 
tissue damage that is often associated with snake bite envenomations, and 
contribute to or in severe cases. even cause death. Many of the hemorrhagic· 
toxins thus far isolated have peen at least partially characterized (BJARNASON 
and Fox, 1988). As a group, snake venom hemorrhagic toxins are zinc-
dependent metalloproteinases and many of them are fibrino(geno )lytic. Also; 
snake venom hemorrhagic toxins, in general, are known to be glycoproteins with 
a varied degree of glycosylation (KUREC:KI and KRESS, 1985; LI et al., 1993; 
SANCHEZ et al., 1987). 
While many of the physicochemical and biochemical traits of hemorrhagic 
toxins have been studied, very little is known about the glycosyl moieties of 
snake venom hemorrhagic toxins. In most cases neither the identities nor the 
functions of these glycosyl residues are known. Recently, two hemorrhagic 
glycoproteins from the venom of Crotalus viridis viridis were isolated and the 
nature of their glycosylation investigated (LI et al., 1993). In this study it was 
reported that the two hemorrhagic toxins both contained Gal-~(1-4)GlcNAc side· 
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chains which could be removed with PNGaseF, thus blocking the enzymatic and 
hemorrhagic activities of the toxins. 
Proteinase H is a hemorrhagic metalloproteinase that was first isolated 
from Crotalus adamanteus venom by KURECKI and KRESS in 1985. At that time it 
was reported that this toxin was the sole agent responsible for the considerable 
hemorrhagic capacity of C. adamanteus venom and that it carried a large degree 
of glycosylation. In the present study we report the characterization of the 
glycosyl moieties of proteinase H and investigate their role in the action of the 
toxin in vivo and in vitro. We demonstrate that the glycosyl moieties of such a 
toxin may be directly involved in the action of the toxin. 
MATERIALS AND METHODS 
Venom and reagents 
Crude C. adamanteus (Eastern diamondback rattlesnake) venom from a 
single pool of snakes from Florida was purchased in lyophilized form from 
Biotoxins, Inc. (St. Cloud, FL, U. S. A.). N,N-dimethylated casein (DMC) was 
purchased from Sigma Chemical Co. (St. Louis, MO, U.S. A.). Azocoll™ and 3-
(N-morpholino )-2-hydroxypropanesulfonic acid (MOPS) were purchased from 
Calbiochem (La Jolla, CA, U. S. A.). PNGaseF from Flavobacterium 
meningosepticum and neuraminidase (NMD) from Vibrio cholerae were purchased 
from Boehringer Mannheim Corp. (Indianapolis, IN, U.S. A.). 
Purification of proteinase H 
The hemorrhagic toxin, proteinase H, was isolated from Crotalus 
adamanteus venom in four liquid chromatographic steps as described in Chapter 
II. Crude venom was separated by open column gel filtration chromatography 
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on a Sephacryl S-200 HR column followed by DEAE anion exchange HPLC and 
sulfopropyl cation exchange HPLC. The formation of a single band on SDS-
p AGE stained with silver nitrate demonstrated the homogeneity of the toxin. 
Amino acid analysis 
Amino acid analysis was performed in the Molecular Biology Resource 
Facility at the William K. Warren Medical Research Institute, University of 
Oklahoma Health Sciences Center under the direction of Dr. Ken Jackson. 
Samples were subjected to hydrochloric acid hydrolysis with 6N HCl at ll0°C 
for 24 hours. Additional samples underwent performic acid hydrolysis for the 
determination of 1/2 cystine. Amino acid analysis was performed by cation 
exchange chromatography (SPACKMAN et al., 1958). Elution was accomplished 
by a two buffer system, using 0.2 N sodium citrate (pH 3.28) and 1.0 M NaCl 
(pH 7.4). Amino acids were detected by on-line post-column reaction with 
ninhydrin (Trione, Pickering Laboratories, Inc.). Derivatized amino acids were 
quantitated by their absorption at a wavelength of 570 nm, except for glutamic 
acid and proline, which are detected at a wavelength of 440 nm. The procedure 
was performed on a totally automated Beckman system Gold model 126 HPLC 
amino acid analyzer. Tryptophan was determined spectrophotometrically. 
Determination of hemorrhagic activity 
Hemorrhagic activity of samples was determined by the intradermal 
injection of 100 µl of treatment solution into the backs of white, female CD-1 
mice (24-26 g), (n=3). After three hours the mice were killed by cervical 
dislocation and the size of the hemorrhagic spot surrounding the injection site 
was measured as described by OWNBY et al. (1984). 
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Polyacrylamide gel electropharesis and electroblotting 
Crude C. adamanteus venom (1.0 µg), proteinase H (0.1 or 0.05 µg), and 
asialofetuin (0.1 µg) used as a control for glycan differentiation were subjected to 
SDS-PAGE. Samples were prepared in sample buffer containing 62.5 mM Tris-
HCl (pH 8.0), 2% SDS, 2% 13-mercaptoethanol and 20% glycerol with 
bromophenol blue as a running front marker, and were heated at 100°C for 5 
minutes. Electrophoresis was carried out using a Pharmacia PhastSystem 
electrophoresis unit and either 12.5 % T homogeneous or 8-25 % T gradient 
acrylamide gels. Samples were applied to the gels and electrophoresis was 
carried out for 65 V • hr for 12.5 % homogeneous gels or 80 V • hr for gradient gels 
according to the manufacturer's instructions as described in Pharmacia 
PhastSystem Technical Bulletin No. 110. Following electrophoresis gels were 
either stained or transferred to PVDF membranes for immunoblotting. Gels 
were stained with Coomassie blue or silver nitrate where indicated. Molecular 
weights were estimated using SigmaMarker Wide Molecular Weight Range 
marker kit No. M-4038 (Sigma Chemical Co., St. Louis, MO, U.S. A.). 
Proteins were transferred to nitrocellulose membranes by semi-dry 
electroblotting procedure using the PhastTransfer™ semi-dry transfer apparatus 
(Pharmacia Biotech, Piscataway, NJ, U.S. A.) as described in the manufacturer's 
instructions. 
Determination of carbohydrate content and percent glycosylation 
Glycosylation was first determined by staining of SDS-PAGE gels with 
periodic acid-Schiff stain (KAPITANY and ZEBROWSKI, 1973). The toxin was 
treated with PNGaseF and then separated by electrophoresis (LI et al., 1993) to 
determine the carbohydrate mass content as well as the linkage of the residues. 
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The molecular weight of the deglycosylated toxin and the non-treated toxin were 
estimated by comparison with molecular weight standards (LI et al., 1993). 
Glycan differentiation 
Identification of the glycan linkage was determined by the susceptibility 
of the sugar moieties to hydrolysis by PNGaseF. The nature of the glycan 
moieties involved was determined using a glycan differentiation kit (Boehringer 
Mannheim Corporation, Indianapolis, IN, U.S. A.) following the manufacturer's 
instructions. Briefly, the toxin sample was first subjected to preliminary analysis 
· by dot-blotting in which 1 µg in 1 µl of Tris-buffered saline (pH 7.5) was vacuum 
blotted onto a PVDF membrane and analyzed to determine the lectin specificity 
for the toxin as described below. Following the preliminary specificity 
determination using the · dot-blotting technique, the samples were 
electrophoresed and transferred to blotting membranes as described above. The 
membranes were incubated with blocking solution overnight at 4°C and then 
reacted with one of the following five different digoxigenin-labeled lectins: 
Galanthus nivalis agglutinin (recognizes terminal Man-a.(1-3)Man, Man-a.(1-
6)Man or Man-a.(1-2)Man), Sambucus nigra agglutinin (specific for Sia-a.(2-6)Gal), 
Maackia amurensis agglutinin (specific for Sia-a.(2-3)Gal), peanut agglutinin 
(recognizes core disaccharide Gal-j3(1-3)GlcNAc), and Datura stramonium 
agglutinin (DSA) (recognizes Gal-j3(1-4)GlcNAc in complex and hybrid N-
glycans or 0-glycans and GlcNAc in 0-glycans). Following the incubation with 
the lectins the membranes were washed and then incubated for 1 hour at room 
temperature with sheep polyclonal anti-digoxigenin Fab fragments conjugated 
with alkaline phosphatase. Following a final wash the membranes were 
developed using a solution of 4-nitroblue tetrazolium chloride (NBT) and 5-
bromo-4-chloro-3-indoyl-phosphate dissolved in dimethylformamide. 
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Effect of EDTA and carbohydrate removal on hemorrhagic activity of proteinase H 
The effects of zinc-chelation by EDTA and deglycosylation of proteinase 
H with PNGaseF on the hemorrhagic activity of proteinase H were determined. 
Briefly, five micrograms of proteinase H in 25 µl of 0.01 M Tris-HCl (pH 7.2) 
were mixed with an equal volume of 5 mM EDTA (pH 8.6) and incubated at 4°C 
overnight. For deglycosylation the same amount of toxin was mixed with 25 ml 
of PBS containing 0.4 units of PNGaseF· and incubated at 37°C overnight. After 
incubation hemorrhagic activity was measured as described above. 
Effect of removal of sialic acid residues on proteolytic and hemorrhagic activities of 
proteinase H 
Proteinase H in aqueous solution (5µg in 10 µl) and Vibrio cholerae 
neuraminidase (0.05 U in 50 µl of sodium phosphate buffer, pH 7.2) were made 
up to 100 µl in buffer and incubated overnight at 37°C for removal of sialic acid 
residues. Following this treatment the sample was tested for proteolytic activity 
on N,N-dimethylated casein and Azocoll™ and for hemorrhagic activity as 
described above. 
Proteolytic activity of proteinase Hon N,N-dimethylated casein 
Proteinase H (5.0 µg) was treated with either EDTA, PNGaseF or 
neuraminidase or left untreated as a control. Each sample was incubated in 1.5 
ml microcentrifuge tubes as described above. Following this incubation period 
the proteolytic activity of the incubation mixture was determined using N, N-
dimethylated casein (DMC) as a substrate CTOHNSON and OWNBY, 1993). DMC 
(0.5 g) was dissolved in 100 ml of 5 mM MOPS buffer (pH 7.2). Samples to be 
tested (50 µl) were transferred to test tubes (n = 3) and 1 ml of the DMC solution 
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added to each tube. Tubes containing 50 µl of MOPS buffer were used as 
negative controls and 1 µg of pronase in 50 µl of MOPS buffer was used as a 
positive control. The tubes were incubated for 30 minutes in a 37°C water bath 
to allow proteolysis to occur. The proteolytic reactions were stopped by heating 
the tubes 5 minutes at 100°C. After heating, 1 ml of 0.4 M NaH2C04 buffer (pH 
8.5) and 1 ml of 0.1 % TNBS was added to each tube for the color development 
reaction. The tubes were incubated for 20 minutes in a 50°C water bath to allow 
for color development. The color development reactions were stopped by the 
addition of 1 ml of 10% SOS and 0.5 ml of 1.0 N HCl to each tube. 200 µl from 
each tube was transferred to a well in a Linbro® (Flow Laboratories, McLean, 
VA, U. S. A.) microtiter plate. The OD at 340 nm of each sample was determined 
using a Thermomax ELISA plate reader (Molecular Devices, Menlo Park, CA, U. 
S. A). 
Proteolytic activity of proteinase H on Azocoll™ 
Proteinase H (5.0 µg) was treated with either EDTA, PNGaseF or 
neuraminidase or left untreated as a control. Each sample was incubated in 1.5 
ml microcentrifuge tubes as described above. After the incubation period 50 µl 
of Tris buffer was added to each tube. Azocoll™ (0.5 g) was then suspended in 
15 ml of 10 mM Tris buffer (pH 7.0) and 100 µl of this suspension added to each 
of the tubes. One tube containing Tris buffer and Azocoll™ suspension only 
and tubes containing EDTA, PNGaseF or neuraminidase without proteinase H 
were used as negative controls. Samples were incubated for 1 hour at 37°C on 
an orbital shaker at 250 rpm. After incubation the samples were centrifuged at 
1000 X g for 15 minutes then 100 µl of the supernatant solution from each 
sample was transferred to the wells of a Linbro® (Flow Laboratories, McLean, 
VA, U.S. A.) microtiter plate. The absorbance of the supernatant solution was 
74 
read at 520 nm using a Thermomax ELISA plate reader (Molecular Devices, 
Menlo Park, CA, U.S. A.). 
Statistics 
The data from each experimental group were subjected to a two-way 
analysis of variance (ANOV A). Variances were expressed as standard errors of 
means. Differences between treatments and controls were calculated and 
analyzed using the Tukey method of multiple comparisons. Differences were 
considered significant if p < 0.05. 
RESULTS 
Purification of proteinase H 
From 2.0 g of crude venom a homogeneous fraction containing 10.5 mg of 
total protein was obtained. Homogeneity of this material was determined as 
described above and is shown in Fig. lA. 
Estimation of molecular weight following deglycosylation 
Proteinase H gave a strong positive reaction with the PAS stain on an 
SDS-PAGE gel. Deglycosylation of proteinase H with PNGaseF resulted in 
complete abolition of the positive reaction with PAS stain reagents. Additionally, 
as seen in Fig. lB, treatment of the toxin with 0.4 units of PNGaseF resulted in an 
increase in the electrophoretic mobility of the toxin. The molecular weights 
estimated by comparison with molecular weight standards were 85.7 kD for the 
non-treated toxin and 50.6 kD for the treated toxin. Removal of sialic acid 
residues by treatment with neuraminidase had no effect on the electrophoretic 
mobility of proteinase H, indicating that sialic acid residues, if any were present, 
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make no significant contribution to the carbohydrate mass content of proteinase 
H. 
Glycan differentiation 
Blotting of the native toxin and deglycosylated toxin was performed as 
described above in methods. In the preliminary dot blotting experiment the 
toxin solution reacted only with digoxigenin-labeled DSA. Following separation 
on SDS-P AGE reaction of the toxin with DSA resulted in the formation of a 
single strong band (Fig. 2) indicating the presence of disaccharide galactose-~(1-
4) N-acetylglucosamine glycosyl residues. 
Amino acid composition 
The amino acid composition of deglycosylated proteinase H was 
determined as described above (Table 1). The minimum molecular weight 
calculated from the amino acid composition data was 49.4 kD. 
Effect of EDTA and carbohydrate removal on hemorrhage 
The effects of EDTA, PNGaseF and neuraminidase on the hemorrhagic 
activity of proteinase H are shown in Table 2. EDTA (2.5 mM final 
concentration) significantly inhibited the hemorrhage induced by proteinase H. 
The occurrence of a small amount of hemorrhage induced by EDTA alone made 
it somewhat difficult to determine whether the toxin still exhibited any 
hemorrhagic capability at all. However, since the hemorrhagic indices from 
mice treated with EDTA alone were not significantly different (p < 0.05) from 
those of mice treated with proteinase H plus EDTA, the hemorrhagic activity of 
proteinase H was completely inhibited. Removal of the carbohydrate moieties 
by 0.4 units of PNGaseF or their oxidation by 0.5 M NaI04 both resulted in the 
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FIG. 1. SDS-PAGE OF HOMOGENEOUS PROTEINASE H. Samples of proteinase H 
(100 ng) were separated by denaturing SDS-PAGE on 8-25 % T gradient 
acrylamide gels. (A) Lane 1, molecular weight markers; Lane 2, 
proteinase H. (B) Lane 1, untreated control proteinase H; Lane 2, 
proteinase H + 5 mM EDTA incubated overnight at 37°C; Lane 3, 
proteinase H incubated overnight at 37°C, Lane 4, proteinase H + 5 mM 
EDT A and 0.4 U PNGaseF incubated overnight at 37°C; Lane 5, 
proteinase H + 0.4 U PNGaseF incubated overnight at 37°C. Visualization 
was performed by staining with silver nitrate. 
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FIG. 2. LECTIN BLOTTING OF PROTEIN ASE H. Following separation by SOS-PAGE 
proteins were transferred to PVDF membranes for blotting against 
digoxigenin-labeled DSA. Lane 1, crude C. adamanteus venom (1.0 µg); 
Lane 2, proteinase H (0.1 µg); Lane 3, asialofetuin control (0.1 µg); Lane 4, 
deglycosylated proteinase H (0.1 µg); Lane 5, PNGaseF control (0.008 U). 
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TABLE 1 AMINO ACID COMPOSITION OF PROTEINASE H 
Amino Acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Pro line 
Glycine 
Alanine 
Valine 
Isoleucine 
Leu cine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
Methionine 
1 / 2 Cystine* 
Tryptophan§ 
Total 
Formula weight 
Residues 
per 
molecule 
20 
24 
24 
35 
15 
28 
20 
19 
30 
30 
14 
11 
14 
11 
12 
10 
33 
5 
355 
49,400 
*Determined as cysteic acid 
§Determined spectrophotometrically 
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TABLE 2 INHIBITION OF PROTEINASE H-INDUCED HEMORRHAGE BY TREATMENT 
WITH DIFFERENT REAGENTS 
Treahnent Mean Hemotthagic Index* % Inhibition 
ProH 238 ± 12 0 
EDTA 28±7 88±6 
ProH+EDTA 33±13 86±6 
ProH + PNGaseF 0±0 100 ±0 
ProH+NMD 209 ± 11 12±5 
Proteinase H was treated with the above reagents as described in the methods 
section of this paper 
*Hemorrhagic indices were calculated as the products of perpendicular 
diameters (in mm) of hemorrhagic spots 
Results are expressed as means of calculated hemorrhagic indices ± SEM (n=3) 
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FIG. 3. INHIBITION OF PROTEOLYTIC ACTNITY OF PROTEIN ASE HON AZOCOLL ™ 
AND N,N-DIMETHYLATED CASEIN (DMC) BY PRE-TREATMENT WITH PNGASEF, 
NEURAMINIDASE OR EDTA. 50 µg of Proteinase H in 10 mM Tris buffer (pH 8.5) 
was treated with PNGaseF, neuraminidase (NMD), or EDTA and then tested for 
proteolytic activity on Azocoll™ and N,N-dimethylated casein as substrates as 
described in methods. Values are expressed as mean OD 520 ± SD (n = 3) and 
OD 340 nm ± SEM (n = 3). *: significantly different from proteinase H control 
(p<0.05). 
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complete inhibition of the hemorrhagic action of the toxin. Desialylation with 
neuraminidase had no effect on the hemorrhagic activity of proteinase H. 
Inhibition of proteolytic activity on N,N-dimethylated casein and Azocoll™ 
Treatment of proteinase H with either EDTA abolished all detectable 
proteolytic activity on Azocoll™ and N,N-dimethylated casein. Treatment with 
PNGaseF inhibited the proteolytic digestion of Azocoll™ and N,N-dimethyl 
casein by 99 ± 2% and 86 ± 12% respectively (Fig. 3). Treatment of proteinase H 
with neuraminidase resulted in a decrease in the proteolysis of Azocoll™ by 
approximately 87 ± 9% (Fig. 3). The desialylated proteinase H showed an 
enhanced proteolysis of N,N-dimethylated casein, having an activity that was 24 
± 12% greater than that of the proteinase H control group. 
DISCUSSION 
The mechanism of action of snake venom hemorrhagic toxins is as yet 
poorly understood. It is generally accepted that their physiological action is due 
to the proteolysis of capillary basement membrane proteins (BARAMOV A et al., 
1989; BARAMOV A et al., 1991). A rather common characteristic of snake venom 
proteins is that of a varying degree of glycosylation (GOWDA and DAVIDSON, 
1992). Many of the snake venom hemorrhagic toxins isolated thus far have been 
shown to be glycoproteins (KUREC:KI and KRESS, 1985; LI et al., 1993; SANCHEZ et 
al., 1987), but relatively little is known about the nature or role of their 
constituent carbohydrate moieties. It was recently demonstrated that the 
carbohydrate moieties of some snake venom hemorrhagic toxins may be 
involved in their hemorrhagic activity (LI et al., 1993). 
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The evidence presented in this study indicates that proteinase H is 
heavily glycosylated. This is indicated by the decrease in electrophoretically 
estimated molecular weight. Anomalies in the electrophoretic mobility of such 
heavily glycosylated proteins prevent an accurate estimation of the molecular 
weight of the native, glycosylated protein, thus the carbohydrate mass content 
cannot be accurately determined. 
Glycosylation is an important aspect of the function of many proteins, 
although ideas on the exact role of glycosylation vary widely. Glycosylation is 
generally thought to play one of three non-specific roles. Glycosylation may (1) 
protect the toxin from proteolysis, (2) provide molecular stability, or (3) provide 
the proper surface charge for molecular activity (WEST, 1986). Glycosylation 
may also play a very specific role such as in intracellular routing of secretory 
proteins and possibly in recognition (WEST, 1986). Glycosylation has been 
shown to be necessary for the binding of certain glycoproteins to their substrate, 
and the binding of the glycoprotein can be competitively inhibited by .the 
isolated glycan moieties of that glycoprotein (SWANSON and Kuo, 1994). Some 
studies also suggest that sugar moieties may play a role in the cellular 
metabolism of certain substances such as LDL (FUJIOKA et al., 1994). 
The loss of activity following deglycosylation suggests that the glycosyl 
moieties of proteinase H play an important role in the activity of the enzyme. 
The changes in the electrophoretic mobility of PNGaseF-treated proteinase H 
both in the presence of EDTA and without EDTA are identical. Because all 
detectable proteolytic activity of proteinase H is inhibited by EDTA it can be 
concluded that no autoproteolysis is occurring to which the decrease in apparent 
molecular weight can be attributed. Additionally, reducing SDS-PAGE of 
PNGaseF-treated proteinase H results in the formation of a single band, also 
indicating that no proteolysis of the toxin has occurred. This then rules out the 
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role of glycans in protection of proteinase H from autoproteolysis, but not 
necessarily from proteolytic degradation by heterologous proteinases. It can be 
concluded that under the experimental conditions described above the loss of 
the hemorrhagic and proteolytic activity of proteinase H must be attributed 
directly to the removal of its glycosyl moieties. A similar study on the enzymatic 
activity of peanut peroxidase (PRX) found that the loss in activity of PRX was 
due to conformational changes in the molecule related to the loss of heme and 
calcium from the enzyme (VAN HUYSTEE and WAN, 1994). Earlier studies on the 
role of zinc ions in the enzymatic activities of snake venom metalloproteinases 
determined that removal of zinc from fibrolase by chelating agents (i.e. EDTA) 
resulted in changes in the three-dimensional conformation of the enzyme, 
specifically, the uncoiling of the a helical structure of the domain containing the 
putative active site of fibrolase (PRETZER, et al., 1992). 
Additionally, the glycosyl moieties may be involved in more than just 
maintenance of the structural integrity of the protein and could be involved 
directly in the interaction of the toxin with substrate and/ or cellular target 
site(s). Carbohydrate moieties are known to be very important in cell adhesion 
strategies, especially those involving selectins. Selectin ligands, such as 
GlyCAM-1, are glycoproteins that have a high mass content of carbohydrates, a 
characteristic that seems to be a common motif among large snake venom 
hemorrhagic toxins (LEVY et al., 1994). 
Glycosylation also plays an important role in maintenance of hemostasis 
as evidenced by the inhibition of platelet aggregation by disintegrins that 
interact with the a.Ilb~3 integrin found on the surface of platelets (LU et al., 1993; 
TAKEYA et al., 1993). It has been proposed that snake venom hemorrhagic toxins 
and disintegrins may be derived from the same precursor molecules by 
proteolytic degradation and that large hemorrhagic toxins may still contain the 
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disintegrin subunit found in the original precursor molecule (KINI and Ev ANS, 
1992). There is also evidence that snake venom disintegrins and plant lectins 
share sequence similarities (KIELISZEWSKI et al., 1994). This supports the idea 
that glycosylation of ligands and carbohydrate identification are important in the 
function of snake venom hemorrhagic toxins. Based on these ideas it seems 
likely that the glycosylation of snake venom hemorrhagic toxins plays an 
important role in the pathogenesis of hemorrhage induced by such toxins. 
The findings of the current study support the idea regarding the activity 
of the hemorrhagic toxin proteinase H and suggest that intact carbohydrate 
moieties of proteinase H maintain the three-dimensional stability of the toxin. 
Further study is necessary to determine what, if any, role glycosyl moieties may 
play in toxin specificity or binding by serving as a ligand or "docking structure". 
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CHAPTER IV 
PATHOGENESIS OF HEMORRHAGE INDUCED BY PROTEINASE 
H FROM EASTERN DIAMONDBACK RATTLESNAKE (CROTALUS 
ADAMANTEUS) VENOM 
ABSTRACT 
The pathogenesis of hemorrhagic effects of a purified hemorrhagic 
toxin, proteinase H from Crotalus adarrianteus venom, was studied. 
Female, white CD-1 mice were injected intramuscularly with 
sublethal doses of the hemorrhagic toxin and tissue samples were 
obtained at 10 minutes, 1, 3 and 24 hours following injection. 
Severe local hemorrhage was observed grossly within 10 minutes. 
Hemorrhage were observed primarily involved the 
microvasculature within the connective tissue of the skeletal 
muscle and within adjacent adipose tissue. Many larger vessels 
were congested with erythrocytes and platelets. By 3 hrs 
inflammatory cell infiltration was observed and necrosis of some 
muscle cells was evident. Transmission electron microscopy 
showed that the capillary endothelium was ruptured, leading to 
hemorrhage per rhexis. Capillary basal laminae were disorganized 
and often wholly or partially absent. 
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INTRODUCTION 
Hemorrhage is a consistent symptom in snake bite envenomation and a major 
contributor to the overall pathology in many cases. Many venoms from snakes 
of the family Viperidae have been found to contain at least one or more 
hemorrhagic proteins. In most cases a single venom contains more than a single 
hemorrhagic toxin. Venom from Crotalus atrox (Western diamondback 
rattlesnake) contains no less than seven distinct hemorrhagic toxins (BJARNASON 
and TU, 1978; NIKAI et al., 1984; NIKAI et al., 1985; BJARNASON et al., 1988). C. 
adamanteus venom, however, has been found to contain a single hemorrhagic 
metalloproteinase (KURECKI and KRESS, 1985; Chapter II). 
Of the many known snake venom hemorrhagic toxins, most have been 
well characterized biochemically. In the last decade investigations of their 
biological mode of action in the induction of hemorrhage have been undertaken. 
Most studies have utilized light and electron microscopic techniques to study the 
pathological effects of hemorrhagic toxins on the vasculature in vivo (QUEIROZ et 
al., 1985; OWNBY and GEREN, 1987; OWNBY et al., 1990; JOHNSON and OWNBY, 
1993). Other studies have characterized the effect of hemorrhagic toxins from 
Bothrops asper venom on cultured endothelial cells (MOREIRA et al., 1994; 
BORKOW et al., 1994, 1995). The purpose of this study was to define the in vivo 
effects of proteinase H on the murine vasculature following intramuscular 
injection. Using light and electron microscopy the pathogenesis of the 
hemorrhage induced by the toxin was thus determined. 
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MATERIALS AND METHODS 
Purification of proteinase H 
Crude Crotalus adamanteus venom (lot No. CA/87 A) was obtained in 
lyophilized form from Biotoxins, Inc. (St. Cloud, FL, U. S. A.) and stored 
desiccated at -20°C until use. The venom was fractionated according to the 
method described by KURECKI and KRESS (1985), with minor modifications. 
Specifically, in the last step of the fractionation a Waters DEAE-5PW semi-
preparative HPLC anion exchange column was used in lieu of the open column 
DEAE-Sepharose used by Kurecki and Kress. Homogeneity of the purified toxin 
was demonstrated by the formation of a single band on a SDS-PAGE gel stained 
with silver nitrate and by analytical C18 reversed-phase HPLC. 
Sample preparation and microscopy 
Experimental female mice (CD-1, Charles River) weighing 22-24 g were 
injected with 100 µl of a solution containing a final dose of either 1 or 5 µg 
toxin/ g mouse weight. Control mice were injected with 100 µl of physiological 
saline. All mice were injected intramuscularly in the lateral aspect of the right 
thigh (biceps femoris muscle) and were killed by cervical dislocation at either 10 
minutes, 1, 3; or 24 hours following injection. Muscle samples were taken from 
the medial aspect of the injected thigh (gracilis and semimebranous muscles) to 
avoid sampling regions that could have possibly suffered mechanical damage 
during the injection. A total of twenty-one mice were used in three separate 
experiments (n=3). 
After sampling the tissue was immediately processed for embedding in 
either paraffin or plastic resin. For embedding in paraffin tissue samples were 
fixed in Bouin's solution overnight and then washed overnight in three changes 
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of 70 % ethanol. The tissue was then embedded in paraffin and 3 µm sections 
were taken, mounted with Permount on glass slides, and stained with 
hematoxylin and eosin for viewing. Tissue samples to be embedded in plastic 
resin were fixed initially in 2 % glutaraldehyde in 0.2 M cacodylate buffer (pH 
7.4) and embedded in Polybed resin (Polysciences, Warrington, PA, U.S. A.) as 
previously described (OWNBY and GEREN, 1987). Thick (0.7 µm) sections were 
taken from blocks of the plastic-embedded tissue using a Sorvall MT-5000 
ultramicrotome with glass knives and were stained with Mallory's trichrome for 
light microscopy. Blocks were selected for sectioning by random selection (n=S). 
Thin sections (70-90 nm) of selected areas of the plastic embedded blocks 
were taken for electron microscopy with a Sorvall MT-6000 ultramicrotome 
using a diamond knife. Sections were picked up on copper grids (200 mesh) and 
stained with methanolic uranyl acetate and lead citrate, observed and 
photographed with a JEOL 100 CX TEMSCAN electron microscope at an 
accelerating voltage of 80 KV. 
RESULTS 
The micrographs that are pictured in this section demonstrate 
observations that were typical of all tissue blocks that were sectioned. No 
hemorrhage was apparent by either gross or light microscopic observation 
following IM injection of the physiologic saline vehicle (Fig. 1). Electron 
microscopic analysis of vascular structures in these control samples confirmed 
normal tissue fine structure. 
Gross observation following intramuscular injections of 1 µg and 5 µg 
proteinase H per gram of mouse weight revealed hemorrhage and edema 
surrounding the site of injection. No effort was made to quantitate this 
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hemorrhage. Within 3 hrs the injected limb was noticeably swollen and turgid 
and edema was evident upon dissection. By 24 hrs the tissue was very dark red 
and noticeably harder than the normal tissue. 
Light microscopy of H & E stained paraffin sections revealed extensive 
areas of hemorrhage within the connective tissues within 10 min after injection 
of the toxin (Fig. 2A) compared with the control (Fig. 1). Figures 2B and 2C 
show that hemorrhage persists without resolution at 1 and 3 hrs. In figure 2C 
the first signs of inflammation are seen as neutrophils (PMNs) appear and are 
associated with necrotic muscle cells. Figure 2C shows visible muscle cell 
damage at a dose of lµg/ g and within 3 hrs while Fig. 3A shows similar damage 
within 1 hr at the 5 µg/ g dose. Myofibrillar clumping and rupture of the 
sarcolemma can be seen in these necrotic muscle cells. Figure 2D shows 
persistent hemorrhage in the form of extravasated and hemolysed erythrocytes 
after 24 hrs and an increase in myonecrosis and PMN infiltration. Figure 3B 
shows extravasated and hemolysed erythrocytes and massive PMN infiltrate as 
well as myonecrosis 24 hrs after injection of the higher dose of proteinase H (5 
µg/g). 
Figure 4A shows an electron micrograph of an intact capillary 10 min 
after injection with proteinase H (5 µg/ g). The capillary is comprised of two 
endothelial cells showing different degrees of damage. One endothelial cell is 
swollen, its plasma membrane is ruptured along the ablumenal surface and 
blebs project from its lumenal membrane. Figure 4B shows a higher 
magnification of these damaged endothelial cell membranes. The other 
endothelial cell pictured in Fig. 4A is not swollen but does contain some 
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FIG. 1. LIGHT MICROGRAPH OF CONTROL SKELETAL MUSCLE. Paraffin-embedded 
muscle tissue stained with H & E 24 hrs after intramuscular injection of 
physiological saline solution. (Bar= 100 µm.) 
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FIG. 2. LIGHT MICROGRAPHS OF SKELETAL MUSCLE ATV ARIOUS TIMES AFTER 
INJECTION OF 1 µg/ g PROTEIN ASE H. The micrographs show paraffin-embedded 
tissue stained with H & E. (A) Skeletal muscle tissue 10 min after injection 
showing extensive hemorrhage, H. (Bar= 50 µm.) (B) Muscle tissue showing 
areas of hemorrhage 1 hr after injection, H. (Bar= 40 µm.) (C) Skeletal muscle 
showing areas of hemorrhage, H, necrotic myocytes, N, and neutrophils, 
arrowheads, 3 hrs after injection. (Bar= 40 µm.) (D) Skeletal muscle 24 hrs after 
injection showing necrotic myocytes, N, and neutrophils, arrowhead. (Bar = 50 
µm.) 
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FIG. 3. LIGHT MICROGRAPHS OF SKELETAL MUSCLE AT 1 AND 24 HOURS AFTER 
INJECTION OF 5 µg/ g PROTEIN ASE H. The micrographs show paraffin-embedded 
tissue stained with H & E. (A) Vacuolated skeletal muscle cells, D, necrotic 
skeletal muscle cell, N, intact capillary, C, and areas of hemorrhage showing 
extravasated and hemolysed erythrocytes, H. (Bar = 50 µm.) (B) Necrotic 
skeletal muscle cell, N, neutrophils, arrowheads, and hemorrhage, H, are visible. 
(Bar = 50 µm.) 
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FIG. 4. ELECTRON MICROGRAPH OF DAMAGED CAPILLARY 10 MINUTES AFTER 
INJECTION OF PROTEINASE H. (A) A capillary with one swollen, S, and one 
non-swollen endothelial cell, Ee, with a swollen mitochondrion, Mi, is shown. 
Note the plasma membrane blebs, B, and intact intracellular junction, J, in the 
swollen endothelial cell. (Bar= 1 µm.) 
(INSET) Magnified view of intact intracellular junction. (Bar= 0.1 µm.) (B) 
Higher magnification of a portion of the damaged endothelial cell pictured in 
Fig. 4A showing disruptions of the plasma membrane, arrowheads, and 
membrane blebs, B. (Bar= 0.2 µm.) 
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FIG. 5. ELECTRON MICROGRAPH OF RUPTURED CAPILLARY 10 MINUTES AFTER 
INJECTION OF PROTEIN ASE H. A large gap where the endothelial cell, Ee, is 
ruptured, double-headed arrow, membrane blebs, B, swollen mitochondrion, 
Mi, are shown. E, erythrocyte; M, skeletal muscle cell. (Bar= 1 µm.) 
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FIG. 6. ELECTRON MICROGRAPH OF RUPTURED CAPILLARY 10 MINUTES AFTER 
INJECTION OF PROTEIN ASE H. (A) M, skeletal muscle cell; N, neutrophil; E, 
erythrocyte. (Bar= 1 µm.) (B) Higher magnification of the area surrounding the 
arrow in Fig. 6A. J, intact intracellular junction; E, erythrocyte; arrowheads, 
endothelial cell fragments. (Bar= 1 µm.) 
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swollen mitochondria. The inset in Fig. 4A shows a high magnification of the · 
intact intracellular junction between the two endothelial cells. In Fig. 5 frank 
rupture of a capillary endothelial cell, a swollen endothelial cell mitochondrion 
and blebbing of the lumenal plasma membrane of the endothelial cell is 
pictured. Fig. 6A and 6B shows an electron micrograph of a ruptured capillary 
10 min after proteinase H (5 µg/ g) injection. Extravasated erythrocytes are 
clearly seen escaping past the remnants of a ruptured capillary endothelial cell 
and its intact intracellular junction, shown at higher magnification in Fig. 6B. 
Cell swelling, mitochondrial swelling, blebbing, and rupturing of the plasma 
membrane (Figs. 4, 5, and 6) were some of the first indications of proteinase H-
induced damage to capillary endothelial cells. Intracellular junctions were not 
visibly affected (Figs. 4A and B; Fig. 6B). These observations indicate that 
proteinase H-induces hemorrhage per rhexis. 
DISCUSSION 
Crude C. adamanteus venom has a very strong capacity to induce 
hemorrhage which is almost entirely attributed to the presence of a single 
hemorrhagic metalloprotease, proteinase H (KUREC:KI and KRESS, 1985).In 
general, crude snake venoms, especially those from the pit vipers, are known to 
induce vascular alterations and abnormalities in hemostasis (KORNALIK, 1991), 
endothelial cell integrity (OWNBY, 1982; LOMONTE et al., 1994; BORKOW et al., 
1995), and blood flow which together aid in bringing about the demise of prey 
animals. Disruption of the blood supply to tissues is also debilitating and may 
aid in the immobilization of prey and in the degradation of body tissues to aid in 
digestion. Among the primary agents responsible for these disruptions are the 
venom hemorrhagic toxins. Most known snake venom hemorrhagic toxins cause 
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hemorrhage per rhexis (OWNBY, 1982; OWNBY, 1990). The mechanism of 
hemorrhage thus induced is thought to be the result of digestion of the 
endothelial basal lamina. Recent studies on the effects of hemorrhagic toxins on 
isolated endothelial cells in vitro demonstrate that the toxins tested caused 
endothelial cells to detach from the substratum but that they were not directly 
toxic to endothelial cells (MOREIRA et al., 1994; BORKOW et al., 1995). However, 
other studies on the pathogenesis of hemorrhagic toxins have shown that severe 
damage to endothelial . cells might occur concomitantly or even prior to 
disruption of the basal lamina (OWNBY and GEREN, 1987). These findings are 
supported by data presented for hemorrhagic toxins from Crotalus ruber ruber 
and Crotalus atrox venoms indicating that these toxins are directly cytotoxic to 
cultured human umbilical vein endothelial cells (HUVEC) (OBRIG et al., 1993). 
Certain venoms, however, have been reported to cause hemorrhage per 
diapedesis. These include venoms from Echis coloratus (SANDBANK et al., 1974) 
and Trimeresurus fiavoviridis (OHSAKA et al., 1975). Thus it is becoming 
increasingly clear that different hemorrhagic toxins may operate by different 
mechanisms of action. The end result of envenomation is usually hemorrhage 
per rhexis regardless of the actual mechanism responsible for the hemorrhage. 
Certain other events in the induction of hemorrhage in vivo suggest that 
the endothelium is directly damaged as a result of interaction with hemorrhagic 
toxins. The occurrence of platelet thrombi and inflammatory cells are suggestive 
of direct damage to the endothelium. Damage to endothelial cells results in the 
release of arachidonic acid metabolites, such as TxA2, TxB2, PGI2, and LTB4, 
P AF, cytokines (IL-1, IL-6, IL-8, TNF-a), and increased surface expression of 
adhesion molecules (ICAM-1, ICAM-2, ELAM) GONES et al., 1992; GERRITSEN 
and BLOOR, 1993; GRACE, 1994). PGI2 is a powerful vasodilator to which 
vascular congestion might be attributed (MONCADA et al., 1976). TxA2 
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stimulates platelet aggregation (VANE et al., 1990). Cytokines, LTB4, and PAF 
(KUBES, et al., 1990) stimulate neutrophil chemotaxis to the site of the injury. 
The damage to muscle cells may be attributed to either ischemia or the 
action of PMNs associated with the inflammation observed. The events 
observed seem to indicate that both ischemia and inflammation had a role in 
inducing muscle cell damage. Myofibrillar clumping, mitochondrial damage, 
and the appearance of electron dense granules, possibly composed of calcium, 
within the mitochondria are other signs of necrosis that occur along with the 
appearance of PMNs. The most likely explanation for these observations is that 
the severe hemorrhage induced by proteinase H leads to ischemic damage of 
muscle cells which are then further damaged as a result of the action of PMNs 
which arrive to "clean up" the damaged tissues. It is impossible to determine, 
strictly on the basis of the data obtained in the current study, the exact primary 
cause of the considerable muscle cell damage that was observed. Either 
ischemia or inflammation, or both, may be involved in the muscle cell damage 
observed. The fact that the onset of muscle cell damage occurs at a relatively 
long time after the administration of proteinase H does suggest that this damage 
is probably secondary to ischemia and inflammation and not a primary effect of 
proteinase H. However, in one study (OWNBY et al., 1978) hemorrhagic toxin b 
(HTb) from C. atrox venom appeared to induce myonecrosis directly. 
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CHAPTERV 
SYSTEMIC HEMORRHAGE INDUCED BY PROTEINASE H FROM 
CROTALUS ADAMANTEUS (EASTERN DIAMONDBACK 
RATTLESNAKE) VENOM 
ABSTRACT 
The systemic effects of a purified hemorrhagic toxin, proteinase H 
from Crotalus adamanteus venom, were studied. Female, white CD-
1 mice were injecte.d intravenously with prote.inase H and tissue 
samples were obtained at 1, 3 and 24 hours after injection. 
Hemorrhage was observed grossly within 1 hour in several 
internal organs including the stomach and small inte.stine, the 
heart, and the lungs. Surface discolorations thought to be petechial 
hemorrhages were observed in the kidneys. The livers of treate.d 
animals were visibly swollen and darkened and lobules were 
accentuate.cl. Tissue samples were taken from the stomach, 
duodenum, heart, lungs, liver, and kidneys and prepared for 
observation by light and electron microscopy. Frank hemorrhage 
was observed by light microscopy in the walls of the stomach and 
duodenum, in the myocardium, and in the lungs. Pulmonary 
hemorrhage was severe, with involvement of nearly all of the 
pulmonary tissue within 3 hrs. At doses of 5 µg/ g, hepatic 
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degeneration was observed by 3 hrs. Renal glomeruli were 
noticeably swollen and the lumena of the proximal convoluted 
tubules indistinct. Closer examination by electron microscopy 
revealed that the endothelial cells comprising the fenestrated 
glomerular capillaries remained intact but signs of degeneration (i. 
e., cytoplasmic swelling, mitochondrial swelling) were observed. 
Proteinase H induces systemic hemorrhage in the heart, lungs, 
stomach, and small intestine, renal glomerulonephropathy, and 
hepatic degeneration. 
INTRODUCTION 
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Several snake venoms and snake venom hemorrhagic toxins have long 
been known to cause systemic hemorrhage. Systemic hemorrhage has been 
induced in several organs including the lungs, brain, heart, kidneys, 
gastrointestinal mucosa, pancreas, liver, adrenal glands, and thyroid by the 
experimental administration of snake venom (PEARCE, 1909; TAUBE and ESSEX, 
1937; FIDLER et al., 1940; NIKAI, et al., 1985; NIKAI, et al., 1986). A few snake 
venom hemorrhagic toxins have also been shown to cause systemic hemorrhage 
(NIKAI et al., 1985; NIKAI et al., 1986; KAMIGUTI et al., 1992) and thereby 
contribute to the lethality of snake venoms. 
Proteinase H is a highly hemorrhagic metalloprotease isolated from C. 
adamanteus venom. The entire hemorrhagic capacity of this venom has been 
shown to be due to proteinase H (KURECKI and KRESS, 1985). In the current 
study the ability of proteinase H to induce systemic hemorrhage in mice was 
investigated by light and electron microscopy. 
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MATERIALS AND METHODS 
Purification of proteinase H 
Crude Crotalus adamanteus venom (lot No. CA/87 A) was obtained in 
lyophilized form from Biotoxins, Inc. (St. Cloud, FL, U. S. A.) and- stored 
desiccated at -20°C until use. The venom was fractionated according to the 
method described by KURECKI and KRESS (1985), with minor modifications 
(Chapter II). In the last step of the fractionation a Waters DEAE-5PW semi-
preparative HPLC anion exchange column was used in lieu of the open column 
DEAE-Sepharose used by Kurecki and Kress. Homogeneity of the purified toxin 
was demonstrated by the formation of a single band on a SOS-PAGE gel stained 
with silver nitrate and by analytical C18 reversed-phase HPLC. 
Sample preparation and microscopy 
Experimental female mice (CD-1, Charles River) weighing 22-24 g were 
injected with 100 µl of a physiological saline solution (PSS) containing a final 
dose of either 1 or 5 µg toxin/ g mouse weight. Control mice were injected with 
100 µl of PSS. All mice were injected intravenously via the median tail vein and 
were killed by cervical dislocation at either 1, 3, or 24 hours following injection. 
Tissue samples were taken from the following organs: heart, lungs, kidney, 
liver, stomach, duodenum. All 6 of these organs were taken from every mouse 
treated. A total of twenty-one mice, three per treatment and three control mice, 
were used in two separate experiments (n=3). 
/1. 
After sampling, the tissue was immediately processed for embedding in 
either paraffin or plastic resin. For embedding in paraffin tissue samples were 
fixed in Bouin's solution overnight and then washed overnight in three changes 
of 70 % ethanol. The tissue thus fixed was then embedded in paraffin and 3 µm 
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sections were taken, mounted with Permount on glass slides, and stained with 
hematoxylin and eosin for viewing. Tissue samples were embedded in plastic 
resin as previously described by OWNBY and GEREN (1987) by initial fixation in 
2 % glutaraldehyde in 0.2 M cacodylate buffer (pH 7.4) followed by embedding 
in Polybed resin (Polysciences, Warrington, PA, U. S. A.). Thick (0.7 µm) 
sections were taken from blocks ofthe plastic-embedded tissue using a Sorvall 
MT-5000 ultramicrotome with glass knives and were stained with Mallory's 
trichrome for light microscopy. Blocks were randomly selected for sectioning 
(n=S). 
Thin sections (70-90 nm) of selected areas of the plastic embedded blocks 
were taken for electron microscopy with a Sorvall MT-6000 ultramicrotome 
using a diamond knife. Sections were picked up on copper grids (200 mesh) and 
stained with methanolic uranyl acetate and lead citrate, observed and 
photographed with a JEOL 100 CX TEMSCAN electron microscope at an 
accelerating voltage of 80 KV. 
RESULTS 
GROSS OBSERVATIONS 
Following injection of the low dose of proteinase H (1 µg/ g) mice were 
not noticeably distressed or otherwise adversely affected. However, mice 
injected with the higher dose of proteinase H (5 µg/ g) were noticeably affected 
within 5 minutes after injection: piloerection was observed over the entire body, 
mice were lethargic and respiration was slowed. These mice died within 3 hrs 
after injection. 
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Heart 
Upon dissection the hearts of mice injected with proteinase H (5 µg/ g) 
were darkened and surface petechiae were visible. When the heart itself was 
dissected areas of hemorrhage were visible within the cut surface of the 
myocardium. 
Lungs 
Upon gross observation petechiae were observed on the lungs of mice 
injected with proteinase H (1 µg/ g) at 3 and 24 hrs after injection. The intensity 
and extent of petechiation increased in a time dependent manner. In mice 
injected with a higher dose of proteinase H (5 µg/ g) frank pulmonary 
hemorrhage involving nearly all of both lungs was observed 3 hrs after injection. 
Liver 
Livers from mice injected with low (1 µg/ g) doses of proteinase H were 
not visibly affected by the toxin upon gross examination at all time periods 
through 24 hrs. Livers from mice injected with 5 µg/ g of proteinase H were 
noticeably wet and heavy 1 hr after injection. In the latter mice, at 3 hrs after 
injection, an enhanced centrilobular pattern was observed on the external and 
cut surfaces of the liver. 
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Stomach 
The stomachs of mice in the low-dose group had a normal, healthy 
appearance at all. time periods. In the high-dose group petechial hemorrhages 
were observed at 1 hr on the serosal surface of the corpus and pylorus of the 
stomach; the mucosal surface of the stomach appeared normal. In these mice, at 
3 hrs, large ecchymoses were observed on the serosal and mucosal surfaces of 
the corpus and pylorus of the stomach. 
Small intestine (Duodenum) 
The small intestines of mice in the low-dose group were not noticeably 
affected. In the large-dose group petechiae and ecchymoses were observed on 
the serosal surface of the small intestine at 1 hr In these mice, at 3. hrs, 
hemorrhage was observed throughout the entire serosal surface of the small 
intestine. 
Kidneys 
The kidneys of mice in the low-dose group had a normal appearance. A 
diffuse petechiation was observed on the surface of kidneys from mice in the 
high-dose group at 3 hrs after injection. Petechiation was also observed in the 
cut-surface of the renal cortex of kidneys from these same mice. 
HISTOLOGY 
Heart 
Interstitial hemorrhage throughout the myocardium was observed by 
light microscopy and cross-striations in cardiac myocytes were disrupted (Fig. 
lB) compared to control (Fig. lA). Vessels larger than capillaries remained 
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intact. 
Lungs 
Histological observations of lungs from mice treated with low doses of 
proteinase H (1 µg/ g) compared with normal control lungs (Fig. 2A) revealed 
that alveolar hemorrhage was time dependent, beginning as small foci of 
hemorrhage which spread throughout the tissue (Fig. 2B). In mice treated with 5 
µg/ g proteinase H intense and diffuse hemorrhage was observed within 1 hr. 
By 3 hrs the normal architecture of the respiratory tissue was completely 
disrupted and no normal tissue is visible (Fig. 2C). 
Liver 
In the low-dose group,Hght microscopy comparison of normal livers (Fig. 
3A) with livers from proteinase H-treated mice revealed glycogen-depletion of 
hepatocytes radiating outward from the central vein at 1 hr and 3 hrs after 
injection. Glycogen was consistently leached from hepatocytes in control groups 
making the cytoplasm stain lightly and in an irregular pattern. Glycogen-
depletion was indicated by the homogeneous acidophilic staining of hepatocyte 
cytoplasm. By 24 hrs after injection the histological appearance of the liver was 
normal. In the high-dose group at 1 hr after injection the pattern of glycogen-
depletion was again apparent and by 3 hrs hepatocytes. showed obvious signs of 
degeneration including swelling, vacuolation, and nuclear pyknosis (Fig. 3B). 
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FIG. 1. LIGHT MICROGRAPHS OF CARDIAC MUSCLE. (A) Control tissue following 
i. v. injection of PSS. (Bar= 50 µm.) (B) Cardiac muscle 3 hours after i. v. 
injection of proteinase H (5 µg/ g). Note extensive hemorrhage, H, throughout 
the interstitial spaces of the myocardium. (Bar= 50 µm.) 
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FIG. 2. LIGHT MICROGRAPHS OF LUNG TISSUE. (A) Control lung after i. v. 
injection of PSS. A, alveolar space; arrowhead, alveolar capillary. (Bar = 50 
µm.) (B) 24 hours after i. v. injection of proteinase H (lµg/ g). H, hemorrhage; 
A, alveolar space; arrowhead, alveolar capillary. (Bar = 50 µm.) (C) 3 hours 
after i. v. injection of proteinase H (5 µg/ g). Note extensive hemorrhage, H, and 
loss of normal histological architecture. (Bar= 50 µm.) 
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FIG. 3. LIGHT MICROGRAPHS OF LIVER. (A) Control liver 3 hours after i. v. 
injection of PSS. (Bar= 50 µm.) (B) Liver 3 hours after i. v. injection of 
proteinase H (5 µg/ g). Nh, vacuolated, degenerative hepatocyte with pyknotic 
nucleus. (Bar= 50 µm.) 
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Stomach 
By comparison with normal murine stomachs (Fig. 4A) hemorrhage was 
observed throughout the lamina propria of the tunica mucosa (Fig. 4B) and in 
the tunica adventitia of the stomach. 
Duodenum 
At 3 hrs after injection of proteinase H (5 µg/ g) extensive hemorrhage 
was observed throughout the lamina propria, muscularis mucosa, submucosa 
and tunica adventitia of the duodenum (Fig. SB) in comparison with control 
duodenum (Fig. SA). 
Kidneys 
Light microscopic observation of paraffin and thick plastic sections 
revealed proximal convoluted tubule with indistinct lumens and swelling and 
congestion of the glomerular capillaries in the high-dose group 3 hrs after 
injection as compared to control kidneys (Fig. 6A). The glomerular architecture 
was intact (Fig. 6B), but swelling decreased the size of the Bowman's space. At 
the electron microscopic level capillary fenestrae were obscured, capillaries were 
congested with erythrocytes and endothelial cells showed signs of degeneration 
including swelling of the cell and mitochondria and dilatation of the 
endoplasmic reticulum (Fig. 7B). There was no apparent change in the 
appearance of the basal laminae of the glomerular capillaries. A glomerulus 
from a control kidney is pictured in Fig. 7 A. 
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FIG. 4. LIGHT MICROGRAPHS OF PYLORIC STOMACH. (A) Control 3 hours after 
i. v. injection of PSS. (Bar= 50 µm.) (B) Pyloric stomach 3 hours after i. v. 
injection of proteinase H (5 µg/ g). Note areas of hemorrhage, H, containing 
extravasated erythrocytes, arrowheads, throughout the lamina propria. 
(Bar = 50 µm.) 
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FIG. 5. · LIGHT MICROGRAPHS OF DUODENUM. (A) Control 3 hours after i. v. 
injection of PSS. (Bar= 50 µm.) (B) Duodenum 3 hours after i. v. injection of 5 
µg proteinase H/ g. Note area of extensive hemorrhage, H, containing 
extravasated erythrocytes, arrowheads, in the submucosa, muscularis mucosa 
and lamina propria; arrowhead, longitudinal view of capillary. (Bar= 50 µm.) 
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FIG. 6. LIGHT MICROGRAPHS OF RENAL CORTEX. (A) Control kidney 3 hours 
after i. v. injection of PSS. G, glomerulus. (Bar= 50 µm.) (B) Kidney 3 hours 
after i. v. injection of proteinase H (5 µg/ g). G, glomerulus; arrowhead, swollen 
glomerular capillary congested with ~rythrocytes. (Bar= 50 µm.) 
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FIG. 7. ELECTRON MICROGRAPHS OF GLOMERULI OF THE KIDNEY. (A) Control 
glomerulus 3 hours after i. v. injection of PSS. E, erythrocyte; P, podocyte. (Bar 
= 1 µm.) (INSET) Higher magnification of area surrounding asterisk showing a 
portion of the endothelial cell, Ee, of the fenestrated glomerular capillary and 
podocyte pedicel, arrowhead. (Bar= 0.5 µm.) (B) Renal glomerulus 3 hours 
after i. v. injection of 5 µg proteinase H/ g showing swollen and congested 
glomerular capillary. E, erythrocyte; arrowhead, podocyte pedicel. (Bar= 2 
µm.) (INSET) Higher magnification of glomerular capillary adjacent to asterisk 
showing cytoplasmic and mitochondrial swelling and dilatation of the 
endoplasmic reticulum of the endothelium of a glomerular fenestrated capillary. 
Ee, endothelial cell; Mi, swollen endothelial mitochondrion; Er, dilatated 
endoplasmic reticulum; arrowhead, podocyte pedicel. 
(Bar= 0.5 µm.) 
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DISCUSSION 
Hemorrhage is generally a complication of snake bite envenomation that 
affects the local tissues (OWNBY, 1990). However, in several viperine venoms, 
particularly Bothrops venoms, systemic hemorrhage is the principal cause of 
death, especially in human victims (KAMIGUTI et al., 1992). In many cases it is 
thought that systemic hemorrhage is the result of snake venom components, 
other than hemorrhagic metalloproteinases, that induce coagulopathies 
(KORNALIK, 1991), although hemorrhagic toxins have been shown to contribute 
to systemic hemorrhage (OHSAKA, 1979). Few hemorrhagic toxins have been 
shown to definitively cause systemic hemorrhage by themselves (NIKAI et al., 
1985; NIKAI et al., 1986). 
The present study conclusively demonstrates that a single hemorrhagic 
toxin, proteinase H, is able to induce hemorrhage in a number of internal organs 
(i. e., heart, lungs, stomach, duodenum) and other pathological changes in the 
liver and kidneys. Hemorrhage is presumably caused per rhexis as proteinase H 
and many other similar toxins have been shown to cause hemorrhage by this 
mechanism (Chapter N; OWNBY, 1982) When administered intravenously to 
mice at high doses (5 µg/ g), proteinase H was able to cause death within 3 hrs. 
Death was presumably the result of respiratory failure due to the destruction of 
the respiratory epithelium as a result of severe pulmonary hemorrhage. Severe 
and extensive hemorrhage in the heart and gastrointestinal tract (stomach and 
small intestine) undoubtedly contributed to the lethality of the toxin. Less 
severe hemorrhage was also induced in the lungs at a lower dose (1 µg/ g) in less 
than 3 hrs. Mice treated with this low dose survived through 24 hrs. 
Hemorrhage did not occur in the liver, although other pathological 
alterations were observed. The enhanced lobular pattern of the liver and the 
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vacuolar degeneration of hepatocytes was suggestive of hepatocellular 
degeneration (MACLACHLAN and CULLEN, 1988) possibly due to ischemic and 
anaerobic hypoxia (SLAUSON and COOPER, 1990). These effects were most likely 
brought about by decreased cardiac output and hypoxia resulting from the 
diminished oxygenating capacity of the lungs. Decreased cardiac output can be 
inferred from the obviously compromised pulmonary venous return and 
negative inotropy due to cardiac myocyte pathology induced by hypoxia in the 
heart. The pathological changes in the liver therefore cannot be conclusively 
attributed to the primary action of proteinase Hand may in fact be a secondary 
result of the toxin's action, although a direct toxic effect cannot be ruled out 
In the kidneys, the swelling of the tubular epithelium could be explained 
by hypoxic ischemia and the alterations in glomerular capillaries were indicative 
of damage to renal endothelium. The congestion and swelling of the glomerular 
capillaries was a paradoxical finding. Hypoxia and a decrease in circulating 
blood volume should have led to constriction of the afferent arterioles perfusing 
the glomeruli (WEST, 1990). Instead, the glomeruli were hyperemic and swollen. 
This may be explained by the damage to the glomerular endothelium. These 
findings differ from those from experimental envenomations with other Crotalid 
venoms (i. e., C. atrox, C. durissus terrificus) in which damage to the visceral 
epithelium, proximal convoluted tubules and the glomeruli occurred (TU, 1977) 
Proteinase H affected only the capillaries of all the tissues sampled. This 
is consistent with the conclusions of MITCHELL and REICHERT in 1886 (Cited by 
OHSAKA, 1979) and LOMONTE et al. (1994) that snake venom induced 
hemorrhage occurred only via the capillaries and that arteries and veins were 
unaffected. 
Interestingly, the effect of proteinase H was not as strong in the kidney or 
liver as it was in the other organs, particularly the lungs and heart. This is not 
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surprising as the toxin is exposed to these organs first due to the route of 
injection via the median tail vein. This is also consistent with the finding that 
1351-labeled Agkistrodon piscivorus venom is concentrated initially in the lungs 
(DEVI, 1971). These observations and the findings presented in the current study 
suggest that proteinase H has a selective effect on the endothelium of different 
tissues and internal organs. 
The findings presented in this study also indicate that a hemorrhagic 
toxin can cause severe and extensive hemorrhage of capillaries in various tissues 
when presented to the lumenal surface of the endothelium, away from the basal 
lamina. This does not necessarily conflict with the idea that hemorrhagic toxins 
cause hemorrhage by degrading the basal lamina, but it does bring forth some 
interesting ideas. Proteinase H still may be causing hemorrhage by digesting the 
basal lamina but, except in fenestrated capillaries, it must cross the endothelial 
barrier first before this can occur. However, in the kidneys, proteinase H clearly 
caused damage to the glomerular endothelium without visibly affecting the 
basal lamina, even at the electron microscopic level. These glomerular lesions 
were very different to those reported by PEARCE (1909) following treatment of 
with crude C. adamanteus venom. PEARCE stated that C. adamanteus venom 
caused, " ... a very striking and interesting exudative glomerular lesion without 
evident alteration of the tubular epithelium," and that this venom caused 
intraglomerular hemorrhage often with exudation and free hemorrhage into the 
Bowman's capsule. In the present study these latter changes were not observed. 
In summary, we have shown that intravenous administration of 
proteinase H causes hemorrhage in many internal organs including the heart, 
lungs, stomach and small intestine. At high doses proteinase H also induces 
hepatocellular degeneration within 3 hrs of administration. In addition, 
proteinase H causes glomerulonephropathy in the form of injury to the 
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endothelial cells of the fenestrated capillaries of the glomeruli without apparent 
alteration to the endothelial basal lamina. 
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CHAPTER VI 
EFFECT OF PROTEINASE H, THE MAIN HEMORRHAGIC TOXIN 
OF CROTALUS ADAMANTEUS VENOM, ON ENDOTHELIAL 
CELLS IN VITRO 
ABSTRACT 
Human umbilical vein endothelial cells (HUVEC), human dermal 
microvascular cells (HMVEC), and rat aorta endothelial cells 
(RAEC) were used to study the in vitro effects of proteinase Hon 
cultured endothelial cells. Proteinase H induced similar 
morphological changes in HUVEC and HMVEC, but not in RAEC. 
Early changes in these cells took the form of the appearance of 
spaces in the monolayer or retraction of cells from each other. The 
cells eventually rounded up and detached from the substratum. 
Proteinase H was preferentially cytotoxic to HMVEC as assessed 
by Trypan blue dye uptake, lactate dehydrogenase release and 
MTT viability assays. All of these effects were time and 
concentration dependent. Proteinase H was not cytotoxic to 
HUVEC nor to RAEC. A decreased plating efficiency of the 
detached HMVEC was further evidence that proteinase H was 
directly cytotoxic to HMVEC. 
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INTRODUCTION 
Hemorrhage is one of the most problematic symptoms accompanying 
envenomation by crotalid snakes in the United States. In most cases this 
hemorrhage is apparent only as local tissue damage but in severe envenomations 
considerable systemic hemorrhage may occur in internal organs such as the 
kidneys, brain, lungs, heart, liver, and intestines (Tu, 1977). As such, 
hemorrhage can often be the major contributing factor to the lethality of a venom 
(OHSAKA, 1979; MEBS, et al., 1988). Many different hemorrhagic toxins have 
been isolated from snake venoms, and the hemorrhagic activity of a venom is 
generally attributed to the presence of such toxins. 
The only consistent clinical treatment of snake bite in the United States is 
the administration of polyvalent (Crotalidae) antivenom produced by Wyeth-
Ayerst (Marietta, PA, U. S. A.). Unfortunately this antivenom may not be 
particularly effective in reducing the hemorrhage that occurs in actual snake 
bites. One of the four venoms used in the production of this antivenom is that of 
Crotalus adamanteus, a highly hemorrhagic venom. Due to these two facts the 
venom is of particular interest in considering the ability of an antivenom to 
neutralize venom induced hemorrhage. A better understanding of the 
mechanism of action of hemorrhagic toxins on vascular endothelium is essential 
in this endeavor. Understanding such a mechanism might enable researchers to 
develop more suitable methods of prevention and treatment of the pathology 
connected with snake venom hemorrhagic toxins. 
Previously, KURECKI and KRESS (1985) isolated an 85.7 kilodalton 
hemorrhagic toxin, proteinase H, from C. adamanteus venom. In the present 
study the effect of this toxin on the viability of rat aorta endothelial cell (RAEC), 
human dermal microvascular endothelial cell (HMVEC), and human umbilical 
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vein endothelial cell (HUVEC) monolayers was investigated using several 
viability assays. The methyl-thiazol-tetrazolium (MTT) assay has been used 
successfully to assay the cytotoxic effects of hemorrhagic toxins on murine 
capillary endothelial cells (LOMONTE et al., 1994). This assay is based on the 
ability of living cells to reduce MTT to formazan via mitochondrial succinate 
dehydrogenase metabolism. This principle was first described in 1953 (BLACK 
AND SPEER) and was developed in the present form of the assay by MOSMANN 
in 1983. Its has the advantage of being rapid, reliable and objective, is very 
accurate, using a relatively small cell population, and delivers reproducible, 
linear results (FOULTIER et al., 1992). Trypan blue dye uptake and lactate 
dehydrogenase release both assess the integrity of the plasma membrane as an 
index of cell viability. The trypan blue assay was used in one recent study to 
show that BaHl, a hemorrhagic toxin from the venom of Bothrops asper, was not 
cytotoxic to bovine endothelial cells (BORKOW et al., 1995). In one other study of 
the effects of hemorrhagic toxins on endothelial cells, neutral red was used to 
assay the cytotoxicity of hemorrhagic toxins from Crotalus ruber ruber and 
Crotalus atrox on human vascular endothelial cells in vitro (OBRIG et al., 1993b). 
The neutral red dye is taken up exclusively by viable cells and concentrated in 
lysosomes. 
The collective results of these studies on the in vitro effects of hemorrhagic 
toxins on endothelial cells are inconclusive at best. Of the three studies 
published thus far there have been different results. However, each study 
employed different cell lines. Studies by LOMONTE et al. (1994) and BORKOW et 
al. (1995) showed that, while BaHl did cause cell detachment, it had no direct 
cytotoxic effect on either immortalized murine capillary endothelial cells or 
bovine aortic endothelial cells. In the study by OBRIG et al. (1993a) HT-1 and HT-
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2 from C. ruber ruber and HT-a and HT-d from C. atrox were all shown to be 
cytotoxic to HUVEC and human renal microvascular endothelial cells (HRMEC). 
In the current study trypan blue dye exclusion, lactate dehydrogenase 
release, MTT metabolism and plating efficiency were used to assess the cytotoxic 
effects of proteinase H on HUVEC, HMVEC, RAEC, human intestinal smooth 
muscle cells (HISM), and sheep tendon fibroblasts (STF). Additionally, two non-
hemorrhagic, non-proteolytic snake venom toxins, ACL myotoxin and myotoxin 
a were used as comparative controls, and trypsin was used as a non-hemorrhagic 
proteolytic control. 
MATERIALS AND METHODS 
Venoms and reagents 
Crotalus adamanteus venom (lot CA/87 A) was purchased from Biotoxihs, 
Inc. (St. Cloud, FL, U. S. A.) in lyophilized form and kept at -20°C until use. 
Endothelial cell growth medium (EBM-MV) with BulletKit™ growth 
supplements was purchased from Clonetics Corp. (San Diego, CA, U. S. A.). 
Medium 199, lactate dehydrogenase assay kit 500-C, and endothelial cell growth 
supplement from bovine pituitary were purchased from Sigma Chemical Co. (St. 
Louis, MO, U. S. A.). Dulbecco's Modified Eagle's Medium (DMEM), 0.25 % 
trypsin, fetal bovine serum (FBS), amphotericin B (fungizone), penicillin-
streptomycin solution, gelatin, heparin, L-glutamine, versene buffer, and 0.4 % 
trypan blue solution were purchased from Gibco BRL Life Technologies 
(Gaithersburg, MD, U. S. A.). The MTT assay kit was purchased from Chemicon 
(Temecula, CA, U. S. A.). 
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HMVEC cell culture 
HMVEC obtained from Clonetics Corp. were seeded in Endothelial cell 
Basal Medium-Microvascular (EGM-MV) supplemented with 5 % FBS, 12 µg/ml 
bovine brain extract, 1 µg/ ml cortisone, 10 ng/ ml epidermal growth factor, 50 
µg/ ml gentamicin, 2.5 µg/ ml amphotericin B (fungizone), 250 U / ml penicillin, 
250 µg/ ml streptomycin in sterile 24-well or 96-well culture dishes (Corning 
Glass, Corning, New York, USA) at a cell density of 5 X 103 cells/cm2. Cells 
were fed with fresh medium every other day until reaching confluency within 8-
10 days. Passages 4 and 5 were used for cytotoxicity studies. 
HUVEC, RAEC, HISM, and STF cell culture 
RAEC were the generous gift of Dr. Paula Grammas, Oklahoma 
University Health Sciences Center, Oklahoma City, OK, USA. STF were 
obtained as secondary cultures from Dr. Larry E. Stein, Oklahoma State 
University, Department of Physiological Sciences, College of Veterinary 
Medicine, Stillwater, OK, USA. HUVEC and HISM were obtained through 
American Type Culture Corporation (). RAEC, HISM, or STF were seeded either 
in 24-well or 96-well culture dishes (Corning Glass, Corning, New York, USA) at 
a density of 5.0 X 103 cells/ml2 and cultured in 0.5 ml or 0.1 ml (24-well and 96-
well dishes, respectively) DMEM supplemented with 10% fetal bovine serum, 2 
mM L-glutamine, 0.01 % (w/v) gentamicin, and 2.5 µg/ml fungizone 
(amphotericin B) at 37°C with 5 % CO2. HUVECs were seeded and cultured in 
an identical conditions except the culture medium was Medium 199 with 10 % 
FBS, 2 mM L-glutamine, 10 µg/ml ECGS, 50 U/ml penicillin, 50 µg/ml 
streptomycin, and 2.5 µg/ ml fungizone. The cells were allowed to achieve 
confluency and experiments were conducted 8-12 days post-seeding. Culture 
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medium was changed every other day. For cytotoxicity assays HUVEC passages 
12, 13 and 14 and RAEC passages 9, 10, and 11 were used. 
Trypan blue and plating efficiency assays 
Cells were cultured in 24-well dishes were washed twice with pre-
warmed medium and then 250 µl of toxin mixed in culture medium was added 
to the appropriate wells. Culture medium with no toxin was used as a negative 
control, culture medium containing 0.1 % Triton X-100 was used as a positive 
cytotoxic control, and 0.25 % trypsin in PBS (pH 7.4) was used as a non-
hemorrhagic, protease comparative control. After the appropriate incubation 
time the treatment medium was remove and the wells were washed with 250 µl 
of warmed HBSS to remove all detached cells. The HBSS wash was added to the 
treatment medium and centrifuged at 200 X g for 5 minutes. The resulting cell 
pellet was washed twice with HBSS and then re-centrifuged after each wash. 
The pelleted cells were resuspended in 500 µl of culture medium and half of 
these cells were counted using a Neubauer improved hemocytometer after the 
addition of 50 µl of 0.4 % Trypan blue. The percent cytotoxicity of the detached 
cells was expressed as the mean percent± SEM of the total number of cells that 
were stained with trypan blue. The remaining cells were replated into sterile 24-
well dishes. 
The replated cells were allowed to attach for 6 hours and were washed 
with HBSS to remove any cells that did not reattach. The reattached cells were 
then trypsinized and both non-reattached and reattached cells counted as 
described above. Plating efficiency was calculated by dividing the number of 
reattached cells by the total number of cells and expressed as a mean percent of 
reattached cells ± SEM. Independent experiments were carried out in triplicate. 
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Lactate dehydrogenase (LD H) release assay 
Cells were cultured and treated as described above for the trypan blue 
assay. Following treatment the medium was removed and replaced with plain 
culture medium to wash each well. The treatment medium was collected into 1 
ml microfuge tubes and centrifuged at 200 X g for 5 minutes. The supernatant 
was carefully decanted and 100 µl assayed for LDH activity (LDHr). The 
pelleted cells were lysed by the addition of 250 µl of culture medium containing 
0.1 % triton X-100 and 100 µl of this was then assayed for LDH activity (LDHd)-
The cells that remained in the culture vessels were washed as described and then 
lysed by the addition of 250 µl of culture medium containing triton X-100. 
Following lysis 100 µl of this mixture was assayed for LDH activity (LDHa). The 
experiment was carried out in triplicate (n=3), and results were expressed as 
mean percent of total LDH released ± SEM: 
% . WH, 
oLDH,eleased = WH WH WH 
,+ a+ d 
MTTassay 
Cells cultured in 96-well dishes were washed three times with 100 µl of 
pre-warmed HBSS prior to treatment to remove any detached cells, cellular 
debris, or metabolites that might interfere with the assay. Toxin was mixed with 
the appropriate culture medium, and 100 µl of this treatment medium was 
added to wells containing confluent cell monolayers and incubated at 37°C, 5 % 
CO2. After the proper incubation time, 10 µl of a 5 mg/ ml solution of MTT in 
PBS {pH 7.4) was added to each well and incubated for 4 hrs. at 37°C, 5 % CO2 to 
allow cells to reduce the MTT to formazan. Following this incubation isopropyl 
alcohol with 0.04 N HCl (100 µl) was added to each well to stop the reaction and 
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to solubilize the formazan crystals. After mixing by repeated pipeting the 
absorbance of each well at 520 nm was read using a Thermomax ELISA plate 
reader (Molecular Devices, Menlo Park, CA, U. S. A) with 650 nm as a reference 
wavelength. The experiment was repeated in triplicate with three identical 
treatments per replicate (n=9). Cell culture medium with no toxin was used as a 
negative control, culture medium containing 0.1 % triton X-100 was used as a 
positive cytotoxic control. Comparative controls included 0.25 % trypsin, 0.5-5.0 
µM ACL myotoxin, and 0.5-5.0 µM myotoxin a. Wells containing no cells were 
included as controls for each treatment to screen for possible artifacts in the MTT 
assay due to each treatment. The results were expressed as a mean percent of 
the negative control ± SEM. 
Morphological changes and scanning electron microscopy 
Changes in the morphology of cells were observed by phase-contrast 
microscopy and scanning electron microscopy. Cells used for SEM observation 
were cultured in 24-well dishes on sterile cover slips under the conditions 
described above. Following treatment cells were fixed in cacodylate buffered 2 
% glutaraldehyde (pH 7.4) for 10 minutes. Following glutaraldehyde fixation 
cells were washed 3 times with 0.2 M cacodylate buffer (pH 7.4) for 5 minutes 
each wash. Cells were fixed with Os04 in cacodylate buffer for 10 minutes, 
washed with water 3 times, then dehydrated in a graded series of acetone (30 % 
- 100 % ). Following the final dehydration step cells were critical point dried and 
then coated with gold-palladium for visualization by SEM. Cells were observed 
with a JEOL JSM-35U scanning electron microscope at 25 KV accelerating 
voltage. 
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Statistics 
The data were analyzed by one-way ANOV A and Dunnet's t-test. 
RESULTS 
Cell detachment 
Proteinase H caused HMVECs to detach from the substratum in a dose 
and ti.me-dependent fashion (Fig. 1). This effect was slower than that seen with 
trypsinizati.on but was nonetheless significant. Proteinase H at a concentration 
of 5 µM caused 76 ± 10 percent of cells to detach within 3 hrs. Nearly 100 
percent of cells were detached within 6 hrs. after treatment with 5 µM proteinase 
H and 0.5 µM proteinase H caused nearly 100 percent detachment of cells within 
24 hrs. 
Trypan blue dye exclusion 
Proteinase H caused treated HMVECs to take up trypan blue dye, 
indicating a compromise in plasma membrane integrity. Significant increases in 
the number of trypan blue-stained cells were observed following treatment of 
HMVECs with 5 µM proteinase H by 3 hrs, and by 6 hours with as little as 0.5 
µM proteinase H (Fig. 2). 
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FIG. 1. HMVEC DETACHMENT INDUCED BY PROTEIN ASE H. Mean percentage of 
total cells detached from the bottom of culture wells after incubation with 
various concentrations of proteinase H (0.5 µM-5.0 µM). Treatments 
significantly different from control (p<0.05): 24 hrs at all concentrations; 6 hrs at 
l, 3, and 5 µM; 3 hrs at 3 and 5 µM; 1 hr at 1, 3, and 5 µM. 
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FIG. 2. TRYPAN BLUE DYE UPTAKE IN HMVEC TREATED WITH PROTEINASE H. 
HMVEC were treated with proteinase H and attached and detached cells 
counted after the addition of 0.4 % trypan blue. Results presented here are 
expressed as the mean percent of the total cells per well stained with trypan blue 
for each treatment group. All treatments, 0.5 - 5.0 µM, were significantly 
different from control (0 µM) (p<0.05). 
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Plating efficiency assay 
Treatment of HMVEC with proteinase H caused cells to detach from the 
substratum and compromised the ability of these detached cells to reattach 
following washing with culture medium as evidenced by a significant decrease 
in their plating efficiency (Fig. 3). It should be noted that the actual number of 
cells that were detached was much greater in the proteinase H-
treated groups compared to the non-treated control. Of those detached cells in 
the control groups nearly half of them reattached within 6 hrs. In the groups 
treated with proteinase H the percent of reattachment of cells ranged from a low 
of about 5 % (5 µM, 24 hrs.) to a high of about 46 % (0.5 µM, 24 hrs). 
Lactate dehydrogenase release assay 
Proteinase H at concentrations up to 5 µM failed to cause LDH release 
from HISM, STF, RAEC or HUVEC. Proteinase H caused significant release of 
LDH from HMVEC at concentrations as low 0.5 µM after 24-hours (Fig. 4). No 
significant increase in LDH release was observed at earlier time periods. 
MTTassay 
Treatment of HMVEC with proteinase H caused a decrease in the MTT-
reducing ability within 6 hrs. at a concentration of 5 µM and Within 24 hrs at 0.5 
µM (Fig. 5). Proteinase H did not affect the MTT-metabolizing ability of the 
other cell types tested. 
Morphological changes 
Following treatment with proteinase H holes began to appear in the 
HMVEC monolayer within 1 hr (Fig. 6). At later time periods, within 3 hrs., 
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FIG. 3. EFFECT OF PROTEINASE HON PLATING EFFICIENCY OF HMVEC. Detached 
cells following proteinase H treatment were washed with fresh culture medium 
and then replated. After 6 hrs. cells which remained unattached were collected 
and counted. Cells that reattached were trypsinized and then counted. Plating 
efficiency is expressed as the mean percent of the total detached cells 
( unattached cells/ total detached cells) that were able to reattach after 6 hrs. 
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FIG. 4. LDH RELEASE ASSAY OF HMVEC TREATED WITH PROTEINASE H. 
Compared to non-treated controls, proteinase H caused significant (p<0.05) 
release of LDH from HMVEC in vitro within 24 hrs at concentrations greater 
than or equal to 0.5 µM. 
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FIG. 5. EFFECT OF PROTEINASE HON MTT-REDUCING ABILITY OF HMVEC. 
Proteinase H caused a significant (p<0.05) decrease in the MTT-reducing ability 
of HMVEC within 6 hours at 5 µM and within 24 hrs at 0.5 µM or greater 
concentrations when compared to controls. 
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FIG. 6. MORPHOLOGICAL CHANGES IN HMVEC INDUCED BY PROTEIN ASE H. 
Cells were treated with 1 µM proteinase H for various periods of time. 
(A) Control cells after 24 hrs. (Bar= 50 µm.) Proteinase H-treated cells after (B) 
1 hr (Bar= 50 µm.); (C) 3 hrs (Bar= 50 µm.); D 24 hrs. (Bar= 50 µm.) 
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FIG. 7. MORPHOLOGICAL CHANGES IN HUVEC INDUCED BY PROTEIN ASE H. Cells 
were treated with 1 µM proteinase H for various periods of time. 
(A) Control cells after 24 hrs. (Bar= 50 µm.) Proteinase H-treated cells after (B) 
1 hr (Bar= 50 µm.); (C) 3 hrs (Bar= 50 µm.); D 24 hrs. (Bar= 20 µm.) 
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FIG. 8. SCANNING ELECTRON MICROGRAPH OF PROTEINASE H-TREATED HMVEC. 
Cells treated with 3 µM proteinase H were analyzed for morphological changes 
after 12 hrs. (A) Control cells. (Bar= 100 µm.); (B) proteinase H-treated cells. 
(Bar== 100 µm.) 
170 
171 
FIG. 8 (cont'd). C, control cells. (Bar= 10 µm.) D, proteinase H-treated cells 
showing blebbing of the plasma membrane (arrowheads). (Bar= 20 µm.) 
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cells were completely rounded and detached from the substratum. Similar 
morphological changes were observed in proteinase H-treated HUVEC (Fig. 7). 
SEM revealed evidence of cellular damage in the form of plasma membrane 
blebbing (Fig. 8). Whereas both HUVEC and HMVEC exhibit similar changes in 
the monolayer specific cellular alterations were observed only in the HMVEC 
groups. This suggests that in both cell types a "non-
specific" action on the extracellular substratum and a much more "cell-specific" 
effect only on the HMVEC. 
DISCUSSION 
Endothelial cell damage has been elicited by a variety of substances 
including hemoglobin (FOLEY et al., 1994), free radicals such as hydroxyl anions 
(V ARANI et al., 1985), H202 (WHORTON et al., 1985), and nitric oxide (VOLK et al., 
1995), neutrophil elastase (WESTLIN and GIMBRONE, 1993), cyclophosphamide 
(KACHEL and MARTIN, 1994), f3-VLDL (TANIMURA et al., 1990), 
lipopolysaccharide (MCGRAT and STEWART, 1969; HARLAN et al., 1983), bacterial 
toxins such as Shiga toxin (KAYE et al., 1993), toxic shock syndrome toxin 1 (LEE 
et al., 1991), and a host of other agents including some snake venom hemorrhagic 
toxins (OBRIG et al., 1993b). General characteristics of damage to endothelial cell 
monolayers in vitro include cell detachment, retraction and plasma membrane 
blebbing, release of endothelial cell markers such as thrombomodulin (SAWADA 
et al., 1992), angiotensin converting enzyme (MATUCCI-CERINIC et al., 1992) and 
von Willebrand factor (BLANN, 1993), and changes in the release and expression 
of various cytokines and cell adhesion molecules (GRACE, 1994). 
The results of the current study indicate that proteinase H is directly 
cytotoxic to HMVEC in vitro. Proteinase H did not exert a cytotoxic effect on the 
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other cell types tested. As proteinase H is a proteolytic enzyme its actions were 
compared to that of a non-hemorrhagic, general protease, trypsin. When cells 
were treated with 0.25 % trypsin for 1 hr to 24 hrs cell cytotoxicity determined 
by either LDH release or trypan blue dye uptake was comparable to or greater 
than that resulting from proteinase H treatment. Trypsin has long been known 
to damage cells due to its proteolytic activity (FRESHNEY, 1987). However, in the 
current study trypsin did not significantly decrease the ability of HMVEC to 
metabolize MTT nor did it significantly decrease the plating efficiency of 
HMVEC. In addition, proteinase H was selectively cytotoxic only to HMVEC 
while trypsin acted on and damaged indiscriminately all the cell types employed 
in the study. Moreover, similar changes were observed in both HMVEC and 
HUVEC monolayers (i. e. appearance of holes in the monolayer) while only in 
HMVEC were morphological changes observed in individual cells. 
Furthermore, trypsinization resulted in the release from the substratum and 
damage of all the cell types thus treated while proteinase H had absolutely no 
discernible effect on RAEC, HISM, or STF. If the action of proteinase H were 
simply proteolytic degradation one would expect some degree of alteration or 
damage to be seen in all the cell types tested and this was not the case. 
Taken together, these findings suggest that the action of proteinase H 
against HMVEC is more than just simple proteolytic damage. These findings 
demonstrate that proteinase H has a specific cytotoxic activity against HMVEC 
and not against arterial or venous endothelial cells in vitro. Cell-specific and 
species-specific variations in the proteins comprising the extracellular 
substratum of or differences in the cell-surface proteins expressed by each cell 
type may explain the selectivity of proteinase H for HMVEC. Also, proteinase H 
may be less active against HUVEC, and greater concentrations of proteinase H 
might elicit the same changes in HUVEC as seen in HMVEC. These findings are 
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consistent with data from studies showing phenotypic heterogeneity in 
endothelial cell populations from different vessels, within the same vessels and 
in different tissue sites (AUERBACH, 1992; TOMLINSON et al., 1991). Such 
heterogeneity has even been reported in the expression of cell-surface receptors 
for bacterial toxins (OBRIG et al., 1993a) 
The early appearance of spaces and detachment of HMVEC is consistent 
with findings by other authors using bovine (BORKOW et al., 1995) and murine 
endothelial cells (LOMONTE et al., 1994) and supports the idea that disruption of 
the capillary basement membrane is one primary effect of snake venom 
hemorrhagic toxins. The death of capillary endothelial cells as seen in this study 
may be secondary to the disruption of the basement membrane, but evidently 
involves more than simple proteolysis in that trypsin does not result in the same 
effect on HMVEC. 
In summary, treatment of human dermal capillary endothelial cells 
(HMVEC) with proteinase H causes the morphological changes (i. e. detachment, 
retraction, blebbing) associated with cell damage as well as membrane 
disruption and metabolic disturbances as evidenced by LDH release and trypan 
blue uptake and decreased MTT reduction respectively. HMVEC plating 
efficiency was also significantly decreased by treatment with proteinase H. 
These changes were not observed in the other cell types tested. These data lead 
us to conclude that proteinase H is directly cytotoxic to HMVEC cells and not to 
HUVEC, RAEC, HISM, or STF in vitro. 
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CHAPTER VII 
DISCUSSION 
Summary 
The purpose of the preceding work was to demonstrate the biochemical 
characteristics and biological actions of the hemorrhagic toxin, proteinase H. In 
particular, the local and systemic effects of proteinase Hin mice and the effects 
of proteinase H on cultured endothelial cells were studied. 
Proteinase H was found to be a large (MW = 85.7 kD), metalloproteolytic 
glycoprotein comprising an estimated 0.7 % of the crude venom (Chapter III). It 
exhibited proteolytic activity against Azocoll™, N,N-dimethylated casein, and 
fibrinogen, accounting for approximately 4.8% of the total proteolytic activity of 
the venom. Proteinase H also exhibited a hemorrhagic activity with a minimum 
hemorrhagic dose of 0.02 µg/ g (Chapter II). Both the proteolytic and 
hemorrhagic activities of proteinase H were inhibited by EDTA and by 
deglycosylation by treatment with PNGaseF (Chapter III). 
Proteinase H was found to have a relatively carbohydrate content 
(Chapter III). Deglycosylation of proteinase H with the N-glycosidase PNGaseF 
resulted in the total removal of all glycosyl moieties detectable by PAS staining 
or lectin blotting. In lectin blotting assays it was also found that proteinase His 
labeled with Datura stramonium agglutinin (DSA) which is specific for glycosyl 
residues containing the disaccharide galactose-f3(1-4)-N-acetylglucosamine in 
complex and hybrid N-glycans. Removal of the glycosyl moieties of proteinase 
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H resulted in a decrease in its molecular weight to 50.6 kD as estimated by SDS-
P AGE. This estimation was corroborated by amino acid analysis which found 
that proteinase H contained 355 residues and had a calculated molecular weight 
of 49.4 kD. Inhibition of the enzymatic and hemorrhagic activity of proteinase H 
by deglycosylation indicated that the glycosyl moieties play and important role 
in the activity of proteinase H (Chapter III). 
Proteinase H induced the formation of fibrin clots from bovine fibrinogen 
by release of fibrinopeptide B and subsequent degradation of the BJ3 subunit of 
fibrinogen (Chapter II). The clotting activity of proteinase H was estimated to be 
equivalent to 5.0 NIH U / mg protein. The clots thus formed differed visibly 
from those formed by treatment of fibrinogen with thrombin in that they were 
more opaque and collapsed to an insoluble precipitate upon vigorous vortexing. 
The characteristics of proteinase H-induced clots were similar to those reported 
by DOWD et al. (1995) for clots formed by treatment of fibrinogen with cathepsin-
L2 from Fasciola hepatica, the only other non-serine proteinase reported to cause 
fibrinogen-clotting. Interestingly, the fibrinogen-clotting activity of proteinase H 
is not inhibited by EDTA or by deglycosylation (Chapter II). These are 
paradoxical findings in that both of these treatments inhibit the proteolytic and 
hemorrhagic activities of proteinase H. The only explanation we were able to 
derive from these data is that proteinase His able to retain some highly specific, 
residual proteolytic activity with which it is able to cause the release of 
fibrinopeptide B, leading to fibrinogen clotting. 
Studies on the pathological effects of proteinase H were also conducted 
(Chapter IV). It was thus determined that the administration of proteinase H via 
intramuscular injection resulted in local hemorrhage per rhexis. Proteinase H 
affected endothelial cells directly, causing cell swelling, mitochondrial swelling, 
ER dilatation, cell membrane blebbing and rupture of the plasma membrane. 
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Hemorrhage was rapid (within 10 min.) and extensive, extending over the entire 
thigh, but platelet plug formation and fibrin deposition were not observed. 
Associated with hemorrhage was myocyte damage (i. e., swelling, SR dilatation) 
and myonecrosis within 1 hr at a dose of 5 µg/ g. Inflammation primarily in the 
form of neutrophil infiltration was also closely associated with the onset of 
myonecrosis. At 24 hrs after injection both myonecrosis and inflammation were 
severe. 
To further the understanding of the role of proteinase Hin the pathology 
of rattlesnake envenomation, in vivo studies were conducted to determine what 
systemic effects proteinase H induced in mice (Chapter V). Following 
intravenous injection of proteinase H (5 µg/ g) severe hemorrhage was observed 
in many internal organs including the heart, lungs, stomach and small intestine. 
At this dose mice died within 3 hrs. Glomerulonephropathy and hepatic 
degeneration were also observed. Renal glomeruli were swollen and congested. 
Damage to the glomerular endothelium in the form of cell and mitochondrial 
swelling and ER dilatation was observed by transmission electron microscopy. 
Endothelial cells remained intact and the basal laminae were not visibly affected. 
In the liver an enhanced lobular pattern was observed grossly at 3 hrs following 
earlier signs of edema. Histologically, glycogen depletion of hepatocytes 
occurred within 1 hr and by 3 hrs many hepatocytes were vacuolated and 
contained pyknotic nuclei. Sinusoidal endothelium and hepatic vascular 
structures were not noticeably affected. It was concluded that these changes in 
the kidney and the liver were most likely secondary events due to ischemia 
and/ or hypoxia brought about as a result of severe pulmonary and cardiac 
hemorrhage. However, the direct action of proteinase H on these tissues cannot 
be ruled out. 
185 
The effect of proteinase H on cultured cells was determined using 
fibroblast, smooth muscle and endothelial cell lines (Chapter VI). It was thus 
determined that proteinase H has no effect on sheep tendon fibroblasts (STF), 
human intestinal smooth muscle cells (HISM), or rat aorta endothelial cells 
(RAEC). Proteinase H does induce morphological changes in human umbilical 
vein endothelial cell (HUVEC) monolayers, causing holes to form in these 
monolayers, but is not cytotoxic to HUVEC. Similar morphological changes in 
HUVEC and murine capillary endothelial cells have been reported for other 
hemorrhagic toxins and are thought to be the result of proteolytic degradation of 
endothelial basal lamina proteins. Proteinase H caused a similar morphological 
change in human dermal microvascular endothelial cells (HMVEC) but was also 
found to be cytotoxic to these cells. Proteinase H induced cell retraction, 
rounding and detachment and membrane blebbing of HMVECs and caused cell 
membrane damage that was assessed by trypan blue dye uptake and LDH 
release assays. Proteinase H treatment also led to the loss of mitochondrial 
reduction of MTT, a further indication of the cytotoxic effect it rendered upon 
HMVECs. These findings correlated well with in vivo observations that 
proteinase H selectively damaged capillary endothelial cells to cause 
hemorrhage per rhexis. 
Conclusions 
The first hypothesis of this dissertation was that proteinase H activity 
(proteolytic and hemorrhagic) is dependent upon glycosylation. The 
observation that removal of glycosyl residues inhibits/ abolishes both of these 
activities allows this hypothesis to be accepted. The exact nature of the role of 
glycosyl moieties cannot be determined from these observations, but inferences 
can be drawn from other studies. I propose that the primary role of the 
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glycosylation of proteinase H is to provide molecular stability for the 
maintenance of an enzymatically active conformation. This is supported by the 
fact that both EDTA-treatment and deglycosylation have the same inhibitory 
effect on proteinase H. As mentioned previously (Chapter II) proteinase H is a 
zinc-dependent metalloproteinase belonging to the metzincin superfamily of 
metalloenzymes. It thus shares certain structure/function characteristics with 
fibrolase, a fibrinolytic enzyme belonging to the same family of enzymes. 
PRETZER et al. (1992) demonstrated, by analysis of circular dichroism spectra, 
that removal of zinc from fibrolase resulted in a conformational change in the 
molecule. Specifically, a decrease in the content of alpha helices in the molecule 
was observed. This decrease was interpreted as the uncoiling of the alpha helix 
containing the enzymatic active site of fibrolase. Thus, removal of a divalent 
metal cation, zinc, resulted in molecular instability leading to the loss of 
enzymatic activity. VAN HUYSTEE and WAN (1994) reported similar changes in a 
different enzyme, peanut peroxidase, after deglycosylation. In that study it was 
reported that removal of N-linked sugars by PNGaseF resulted in the loss of a 
calcium ion from the enzymatic active site of peanut peroxidase. This was 
associated with loss of alpha helical content of the molecule which was 
interpreted as the uncoiling of the enzymatic active site. In both of these cases 
the loss of a metal cation from the active site is associated with loss of alpha 
helical content and concurrent loss of enzymatic activity. Deglycosylation is 
related to the loss of a divalent metal cation in certain metalloenzymes. It can 
thus be inferred that, in particular enzymes, molecular stability is associated 
with glycosylation. Proteinase H is such an enzyme. 
Microvascular hemorrhage can occur via two routes. In hemorrhage per 
rhexis, the endothelial cells forming capillaries are directly lysed and 
hemorrhage occurs by virtue of this microvascular disruption. In hemorrhage 
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per diapedesis the intracellular junctions of endothelial cells are broken allowing 
extravasation of blood components to occur intracellularly. In the current study 
it has been clearly demonstrated that proteinase H induces hemorrhage per 
rhexis. This confirms the second hypothesis of the dissertation. This finding, 
taken together with the observation of systemic hemorrhage, is important in 
considering the actual mechanism by which proteinase H induces hemorrhage. 
The dramatic pulmonary, cardiac, and gastrointestinal hemorrhage after 
intravenous injection strongly suggests that proteinase H directly lyses the 
capillary endothelium in these organs. This is particularly apparent in 
considering the lungs. The pulmonary microvasculature is a characteristically 
tight barrier. As such, proteinase H, a relatively large protein, must cross the 
endothelial cell barrier to act on the endothelial basal lamina. It is doubtful that 
it is able to do so, yet it still induces hemorrhage per rhexis in the lungs. Thus, 
proteinase H directly lyses the vascular endothelium. 
Proteinase H appears to be partially selective for the pulmonary 
endothelium. This is particularly obvious when considering that intravenous 
administration of proteinase H induced very severe hemorrhage in the lungs 
without inducing any hemorrhage in skeletal muscle tissue. It is known that 
proteinase H is able to induce hemorrhage in skeletal muscle after intramuscular 
injection. After intravenous injection the pulmonary and skeletal muscle 
vasculature are both exposed to proteinase H. This leads one to conclude that 
proteinase H "prefers" the pulmonary, cardiac, and GI microvasculature. This is 
most likely due to phenotypic heterogeneity of different endothelial cell 
populations determined by their location within the body. This kind of 
heterogeneity is well documented (AUERBACH, 1992; HEWETT and MURRAY, 
1993; PETZELBAUER et al., 1993). OBRIG et al. (1992) even demonstrated this kind 
of phenotypic heterogeneity regarding the expression of cell surface receptors 
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specific for a bacterial toxin. The evidence described above would suggest that a 
cell surface receptor may exist for proteinase H on certain microvascular 
endothelial cells and that the expression of this receptor varies between 
endothelial cell populations. If there is such a receptor, the microvascular 
endothelium of skeletal muscle clearly expresses it, but proteinase H seems to 
prefer the microvascular endothelium of other organs when administered 
intravenously. This is an additional possible role of the glycosyl moieties of 
proteinase H: the function of ligand recognition and/ or binding. 
The third hypothesis of the dissertation, that proteinase H is directly 
cytotoxic to microvascular endothelial cells, was also supported by the findings 
of the study. Proteinase H was directly cytotoxic to cultured HMVEC (Chapter 
VI). More importantly, proteinase H was not cytotoxic to sheep tendon 
fibroblasts, human intestinal smooth muscle cells, rat aorta endothelial cells, nor 
human umbilical vein endothelial cells. The predominant theory regarding the 
action of snake venom hemorrhagic toxins is that they digest the endothelial 
basal lamina to induce hemorrhage per rhexis. As mentioned above, it seems 
clear that proteinase H induces hemorrhage per rhexis by direct lysis of 
endothelial cells. In the cell culture studies cells were plated on plastic and were 
grown without the assistance of pre-coating vessels with an artificial "basal 
lamina". Proteinase H was still cytotoxic to HMVEC, suggesting that it is not 
necessary to digest the basal lamina to induce cell lysis. The initial response of 
HMVEC ( and HUVEC) to proteinase H was retraction. This seems to suggest 
that the cells respond directly to the presence of proteinase H. Additionally, 
proteinase H was cytotoxic after application to the "lumenal" surface of cultured 
HMVEC, further evidence that the basal lamina need not be involved. 
According to the Handbook of Toxinology there are seven different 
classes of cytotoxins (SHIER and MEBS, 1990). These include cytolytic toxins, 
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toxins that inhibit protein synthesis, enterotoxins, toxins altering genetic 
expression, toxins acting on the cytoskeleton, toxins acting on ion channels and 
synapses, and bacterial endotoxins. Due to mechanistic considerations and 
differences in molecular structures I do not think that proteinase H can be 
reasonably considered as belonging to any of these classes of cytotoxins except 
possibly for cytolytic toxins and enterotoxins. 
There are four subclasses of cytolytic toxins: pore-forming toxins, 
cytolytic enzymes, detergent-like toxins, and toxins acting via unknown 
mechanisms. Pore-forming toxins come in a variety of sizes, isoelectric points 
and molecular structures. It is conceivable that proteinase H acts via this 
mechanism, although there is no data to support this. Cytolytic enzymes 
directly destroy the plasma membrane or make the plasma membrane more 
susceptible to lysis by enzymatic digestion of membrane phospholipids. Thus, 
these toxins are phospholipases. There is no evidence to suggest that proteinase 
H is a phospholipase, so I believe that proteinase His not a cytolytic enzyme. 
Detergent-like toxins are generally non-protein, surfactant molecules. It is 
unlikely that proteinase H operates via this mechanism. At present, if proteinase 
H were included as a cytolytic toxin it would most likely be classified as one 
with an unknown mechanism. 
Enterotoxins act on the digestive tract and inhibit water absorption 
primarily by disrupting ion transport in gut epithelial cells via a G-peptide 
dependent receptor-mediated mechanism. Proteinase H can obviously be 
excluded from this class of toxins in that it does not induce the same 
physiological changes as enterotoxins. However, proteinase H may act on 
endothelial cells via a similar mechanism of action, i. e., receptor-mediated 
cytotoxicity. In fact, one enterotoxin, Shiga toxin, is a relatively large protein (70 
kD) that has been shown to bind to cell surface glycolipid receptors on 
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endothelial cells in vitro (OBRIG et al., 1993). The mechanism of action of Shiga 
toxin is not clear but the end result is a reduction in cell viability and protein 
synthesis. The cytotoxic effect of proteinase H against HMVEC in vitro follows a 
similar time course as that shown for Shiga toxin against HUVEC and human 
renal microvascular endothelial cells (HRMEC) in vitro. As mentioned in 
Chapter VI, this effect is much slower than hemorrhage actually occurs in vivo. 
Shiga toxin cytotoxicity was enhanced by the addition of tumor necrosis factor 
(TNF) indicating that there are other factors involved in its in vivo activity. This 
may also be true for proteinase H. 
Another interesting observation regards the role of proteolysis in the 
activity of proteinase H. If the action of proteinase H is due to its proteolytic 
activity one might expect it to have the same effect on all cells, much like trypsin. 
This was not the case, and there are· three explanations that come readily to 
mind. First, the proteolytic activity of proteinase H may not play a role in its 
cytotoxic activity. This would not be entirely surprising as proteinase His not 
highly proteolytic on any of the substrates it has been tested against when 
compared to trypsin, pronase, or other proteases. If the proteolytic activity of 
proteinase His not involved in cytotoxicity then what is its role? The answer to 
this question is elusive. A second, and perhaps more plausible, explanation is 
that the proteolytic activity of proteinase H is highly specific for proteins 
produced by certain microvascular endothelial cells. This would explain the 
preferential cytolytic effect of proteinase H in vivo as well as the selective 
cytotoxic effect of proteinase H in vitro. The third explanation is that the 
cytotoxic activity of proteinase His due to the presence of cell surface receptors 
on certain microvascular endothelial cells. 
Either of the latter two hypotheses of the selective cytotoxic effect of 
proteinase H might also explain the in vivo observations of 
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glomerulonephropathy and proximal convoluted tubule swelling. Proteinase H 
was found to induce damage to glomerular endothelial cells and congestion of 
glomerular capillaries. Initially one would expect that glomerular damage 
would be due to hypoxic ischemia as a result of decreased vascular perfusion 
and decreased oxygenation of erythrocytes because of pulmonary and cardiac 
hemorrhage. Instead, glomerular capillaries were hyperemic. Thus the 
glomeruli were well-perfused. This paradoxical observation suggests that the 
glomeruli were directly damaged. A similar conclusion may be drawn from the 
swelling of the proximal convoluted tubular epithelium. Hepatocyte 
degeneration is most likely due to ischemic conditions in the liver, but a direct 
toxic effect of proteinase H cannot be ruled out. Hypothetically, proteinase H 
may be toxic to glomerular endothelial cells, proximal convoluted tubule 
epithelial cells and hepatocytes. If this is the case, it would appear that a 
common receptor or target molecule exists on all the cell types affected. One 
weakness in the work conducted to asses the toxic affects of proteinase Hin vivo 
is that, except for skeletal muscle, only tissues that were visibly affected were 
selected for microscopic observation. Because of this it cannot be concluded that 
proteinase H was not cytotoxic to cells in other tissues. Future studies might 
address this. 
Proteinase H also exhibited other characteristics that are most interesting 
such as the observation that proteinase H induces fibrinogen-clotting. It should 
be emphasized that this activity was not demonstrated in vivo. If it does actually 
occur in vivo, the role of this activity, if any, in the function of proteinase Has a 
hemorrhagic toxin is uncertain. Snake venom procoagulants have previously 
been implicated in the induction of hemorrhage by virtue of their fibrinogen-
depleting action. Such agents induce the slow formation of fibrin to form 
microthrombi which do nothing to promote hemostasis but instead compromise 
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the clotting ability of the blood. This is a likely explanation of the fibrinogen-
clotting activity of proteinase H. 
A final observation about the in vivo activity of proteinase H is the 
conspicuous absence of platelet plugs in intact vessels following treatment with 
proteinase H. Unfortunately, it is impossible to conclude that platelet plugs 
definitely do not form because they may simply not be present in the tissue 
samples that were analyzed. They may have been present in other samples that 
were not analyzed. If, in fact, no platelet plugs are formed this is quite 
interesting in light of the fact that this is a common observation reported for 
hemorrhage induced by various other snake venom hemorrhagic toxins. Platelet 
plug formation is also indicative of endothelial cell damage. The absence of 
platelet plugs suggests that proteinase H exhibits disintegrin-like activity. This 
is a reasonable suggestion in light of the KINI and EVANS (1992) hypothesis that 
disintegrins and snake venom metalloproteinases are derived from a common 
precursor molecule. According to this hypothesis proteinase H, a high 
molecular weight metalloproteinase, would be expected to possess both a 
metalloproteolytic domain and a disintegrin-like domain. This expectation is 
supported by the absence of platelet plug formation following proteinase H 
administration in vivo and thus supports the Kini and Evans hypothesis. For this 
reason, future studies on proteinase H should include experiments of the 
inhibition of platelet aggregation. 
In final summary, all three hypotheses of the dissertation were 
accepted. The proteolytic and hemorrhagic activities of proteinase H were 
dependent upon glycosylation. Proteinase H induced hemorrhage per rhexis 
secondary to microvascular endothelial cell cytotoxicity. Proteinase H was 
directly cytotoxic to microvascular endothelial cells in culture. 
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